var title_f6_47_6896="New onset urticaria";
var content_f6_47_6896=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F78544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F78544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute urticaria on the trunk",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6896=[""].join("\n");
var outline_f6_47_6896=null;
var title_f6_47_6897="Temporal arteritis PI";
var content_f6_47_6897=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F65142&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F65142&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 509px\">",
"   <div class=\"ttl\">",
"    Temporal arteritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 489px; height: 486px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Temporal arteritis is also called giant cell arteritis. It frequently affects medium and large artery branches that originate from the neck and travel into the head. People with temporal arteritis sometimes have a raised, tender blood vessel located in the temple.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6897=[""].join("\n");
var outline_f6_47_6897=null;
var title_f6_47_6898="Skin biopsy NSF CD34 cells I";
var content_f6_47_6898=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F76644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F76644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    High power image showing immunohistochemical staining for CD34 of a skin biopsy from a patient with nephrogenic systemic fibrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 293px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A high magnification image with immunohistochemical staining reveals abundant elongated cells that express the cell surface antigen CD34 (brown) and produce the protein procollagen I (magenta). This combination of findings identifies the cells as circulating fibrocytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     With permission from: Shawn E Cowper, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6898=[""].join("\n");
var outline_f6_47_6898=null;
var title_f6_47_6899="Patient information: Should I switch to an insulin pump? (The Basics)";
var content_f6_47_6899=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/85799\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/11/35006\">",
"         Insulin pump",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/52/37699\">",
"         Patient information: Carb counting and your child&rsquo;s diet (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/2/36898\">",
"         Patient information: Diabetic ketoacidosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?5/33/5651\">",
"         Patient information: Giving your child insulin (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?14/12/14531\">",
"         Patient information: Low blood sugar in people with diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/43/692\">",
"         Patient information: Type 1 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/44/33475\">",
"         Patient information: Type 2 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/58/28579\">",
"         Patient information: Using insulin (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?34/31/35317\">",
"         Patient information: Diabetes mellitus type 1: Insulin treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/28/18886\">",
"         Patient information: Diabetes mellitus type 2: Insulin treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/63/4083\">",
"         Patient information: Hypoglycemia (low blood sugar) in diabetes mellitus (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/61/32726\">",
"         Patient information: Reducing the costs of medicines (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Should I switch to an insulin pump? (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H4130033\">",
"      <span class=\"h1\">",
"       What is an insulin pump?",
"      </span>",
"      &nbsp;&mdash;&nbsp;An insulin pump is a device that delivers insulin to the body. Some people with diabetes use an insulin pump instead of insulin shots as a way to get their insulin treatment.",
"     </p>",
"     <p>",
"      An insulin pump is about the size of a cell phone. People wear or carry their pump on their body all the time.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130048\">",
"      <span class=\"h1\">",
"       How does an insulin pump work?",
"      </span>",
"      &nbsp;&mdash;&nbsp;An insulin pump delivers insulin through a thin tube that goes under the skin (",
"      <a class=\"graphic graphic_figure graphicRef84008 \" href=\"UTD.htm?34/11/35006\">",
"       figure 1",
"      </a>",
"      ). People need to use a small needle (or a device that has a small needle) to put the tube under their skin. Then they cover the tube with a patch and leave it in place for 2 to 3 days. After this time, the tube needs to be taken out and put under the skin in a different spot.",
"     </p>",
"     <p>",
"      Only short-acting (regular) insulin or rapid-acting insulins are used with a pump. If you use a pump, your doctor or nurse will help you figure out the amount of insulin that you should get continuously&mdash;all day and night. This is called a &ldquo;basal&rdquo; rate. Then, before meals, you will program your pump to give a higher dose of insulin (called a &ldquo;bolus&rdquo;). This amount will depend on what you plan to eat and what your blood sugar level is.",
"     </p>",
"     <p>",
"      Just like people who use insulin shots, people with an insulin pump need to check their blood sugar level a few times each day. This usually involves pricking a fingertip 4 or more times a day.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130080\">",
"      <span class=\"h1\">",
"       Who might use an insulin pump?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People of all ages can use an insulin pump. Most often, insulin pumps are used in people with type 1 diabetes. But more and more, people with type 2 diabetes are using them.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130095\">",
"      <span class=\"h1\">",
"       What are the benefits of an insulin pump?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Compared to insulin shots, an insulin pump has the following benefits:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        It does not involve getting insulin shots every day.",
"       </li>",
"       <li>",
"        People with an insulin pump have more choices about when and what they eat. They don&rsquo;t always have to plan their meals in advance. They can just give themselves a bolus dose to cover the food they plan to eat and the activities they plan to do.",
"       </li>",
"       <li>",
"        Using an insulin pump might help people keep their blood sugar levels under better control, with fewer highs and lows.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130110\">",
"      <span class=\"h1\">",
"       What are the downsides of an insulin pump?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The downsides of an insulin pump include the following:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        It takes time to learn how to program and use an insulin pump.",
"       </li>",
"       <li>",
"        If the tube slips out of the skin or gets a kink in it, people won&rsquo;t get any insulin. Then their blood sugar level can get too high, which can lead to serious problems.",
"       </li>",
"       <li>",
"        Insulin pumps usually cost more than insulin shots.",
"       </li>",
"       <li>",
"        People sometimes gain weight when they use it, because they have more choices about what and when they can eat.",
"       </li>",
"       <li>",
"        Wearing or carrying an insulin pump all the time can be bothersome.",
"       </li>",
"       <li>",
"        The area where the tube goes into the skin can get infected.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130125\">",
"      <span class=\"h1\">",
"       How do people wear or carry their pump?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People wear or carry their pump in different ways. They can put it in their waistband, shorts, underwear, or bra. They can also keep it in their pocket or clip it to a belt.",
"     </p>",
"     <p>",
"      At night, people can put their pump in their pajamas or clip it to a blanket, sheet, or pillow.",
"     </p>",
"     <p>",
"      Most people can disconnect their pump and take it off for short periods of time, about 1 to 2 hours. That way, people don&rsquo;t need to wear it when they shower, bathe, swim, or have sex.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130140\">",
"      <span class=\"h1\">",
"       How do I decide if I should switch to an insulin pump?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You, your doctor, and your family will need to discuss whether an insulin pump is right for you. To help you decide, discuss the benefits and downsides of using a pump, and your individual situation.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130155\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/43/692?source=see_link\">",
"       Patient information: Type 1 diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=see_link\">",
"       Patient information: Type 2 diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/58/28579?source=see_link\">",
"       Patient information: Using insulin (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/33/5651?source=see_link\">",
"       Patient information: Giving your child insulin (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/2/36898?source=see_link\">",
"       Patient information: Diabetic ketoacidosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/52/37699?source=see_link\">",
"       Patient information: Carb counting and your child&rsquo;s diet (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/12/14531?source=see_link\">",
"       Patient information: Low blood sugar in people with diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/31/35317?source=see_link\">",
"       Patient information: Diabetes mellitus type 1: Insulin treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/28/18886?source=see_link\">",
"       Patient information: Diabetes mellitus type 2: Insulin treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?3/63/4083?source=see_link\">",
"       Patient information: Hypoglycemia (low blood sugar) in diabetes mellitus (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       Patient information: Reducing the costs of medicines (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?6/47/6899?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 85799 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-EE4A41C0CF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6899=[""].join("\n");
var outline_f6_47_6899=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130033\">",
"      What is an insulin pump?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130048\">",
"      How does an insulin pump work?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130080\">",
"      Who might use an insulin pump?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130095\">",
"      What are the benefits of an insulin pump?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130110\">",
"      What are the downsides of an insulin pump?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130125\">",
"      How do people wear or carry their pump?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130140\">",
"      How do I decide if I should switch to an insulin pump?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130155\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/85799\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/11/35006\">",
"      Insulin pump",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/52/37699?source=related_link\">",
"      Patient information: Carb counting and your child&rsquo;s diet (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/31/35317?source=related_link\">",
"      Patient information: Diabetes mellitus type 1: Insulin treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/28/18886?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Insulin treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/2/36898?source=related_link\">",
"      Patient information: Diabetic ketoacidosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/33/5651?source=related_link\">",
"      Patient information: Giving your child insulin (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/63/4083?source=related_link\">",
"      Patient information: Hypoglycemia (low blood sugar) in diabetes mellitus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/12/14531?source=related_link\">",
"      Patient information: Low blood sugar in people with diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/43/692?source=related_link\">",
"      Patient information: Type 1 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=related_link\">",
"      Patient information: Type 2 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/58/28579?source=related_link\">",
"      Patient information: Using insulin (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_47_6900="Terbinafine (topical): Drug information";
var content_f6_47_6900=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Terbinafine (topical): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?38/53/39763?source=see_link\">",
"    see \"Terbinafine (topical): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?1/30/1507?source=see_link\">",
"    see \"Terbinafine (topical): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9566190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      LamISIL AT&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9566191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Lamisil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9566196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Topical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9568028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Athlete's foot (tinea pedis):",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Cream:",
"     </i>",
"     Apply to affected area once daily for at least 1 week, not to exceed 4 weeks [OTC/Canadian/prescription formulations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Gel:",
"     </i>",
"     Apply to affected area once daily for at least 1 week, not to exceed 4 weeks [OTC/Canadian/prescription formulations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Solution:",
"     </i>",
"     Apply to affected area once daily for at least 1 week, not to exceed 4 weeks [OTC/Canadian/prescription formulations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cutaneous candidiasis:",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Cream:",
"     </i>",
"     Apply to affected area once or twice daily for 7-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Gel:",
"     </i>",
"     Apply to affected area once or twice daily for 7-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Solution:",
"     </i>",
"     Apply to affected area once or twice daily for 7-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Ringworm and jock itch (tinea corporis/tinea versicolor, tinea cruris):",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Cream:",
"     </i>",
"     Apply to affected area once daily for at least 1 week, not to exceed 4 weeks [OTC formulations]; apply to affected area once or twice daily for 2 weeks in tinea versicolor [Canadian/prescription formulation]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Gel:",
"     </i>",
"     Apply to affected area once daily for 7 days [OTC formulations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Solution:",
"     </i>",
"     Apply to affected area once daily for 7 days in tinea corporis and tinea cruris [OTC formulations]; apply to affected area once or twice daily for 2 weeks in tinea versicolor [Canadian/prescription formulation]",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9568027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?1/30/1507?source=see_link\">",
"      see \"Terbinafine (topical): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;text-align:justify;display:inline\">",
"     <b>",
"      Athlete's foot (tinea pedis), ringworm (tinea corporis), jock itch (tinea cruris), cutaneous candidiasis:",
"     </b>",
"     Topical cream, gel, solution: Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F9568029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F247718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical, as hydrochloride: 1% (12 g [DSC], 15 g, 24 g [DSC], 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LamISIL AT&reg;: 1% (12 g, 15 g, 24 g, 30 g, 36 g) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LamISIL AT&reg;: 1% (6 g, 12 g) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, topical, as hydrochloride [spray]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LamISIL AT&reg;: 1% (30 mL) [contains ethanol]",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F10076341\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical, as hydrochloride: 1% (12 g, 24 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lamisil&reg;: 1% (15 g, 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, topical, as hydrochloride [spray]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lamisil&reg;: 1% (30 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9566194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Cream",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F247719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Antifungal for the treatment of tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm) [OTC/prescription formulations]; tinea versicolor [prescription formulations]",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9566186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Terbinafine may be confused with terbutaline",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9568009\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;text-align:justify;display:inline\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Burning, contact dermatitis, dryness, exfoliation, irritation, pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Irritation, stinging",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F9601565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to terbinafine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F247709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse events:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Local irritation: If irritation/sensitivity develops, discontinue therapy and institute appropriate alternative therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For topical use only. Not intended for ophthalmologic, oral, or vaginal administation.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F247713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9568004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies with systemic terbinafine. Systemic absorption is limited following topical application.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F9568007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Following oral administration, terbinafine is excreted into breast milk. (Refer to the Terbinafine, Systemic monograph for additional information). Systemic absorption is limited following topical application. Nursing mothers should not apply topical formulations to the breast.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F9572927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (LamISIL AT Jock Itch External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (12 g): $8.15",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Terbinafine HCl External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (15 g): $6.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (LamISIL Advanced External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (12 g): $8.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (LamISIL AT External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (30 mL): $8.15",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (LamISIL AT Spray External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (125 mL): $8.15",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (LamISIL External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (30 mL): $84.79",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10961914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Amizil (PH);",
"     </li>",
"     <li>",
"      Antifan (CZ, EE);",
"     </li>",
"     <li>",
"      Dermafin (MY);",
"     </li>",
"     <li>",
"      Dermasil (IL);",
"     </li>",
"     <li>",
"      Funginix (DK);",
"     </li>",
"     <li>",
"      Fungizid (DE);",
"     </li>",
"     <li>",
"      Fungster (BE);",
"     </li>",
"     <li>",
"      Futeshu (CL);",
"     </li>",
"     <li>",
"      Interbi (HK, ID);",
"     </li>",
"     <li>",
"      Lamifen (PH);",
"     </li>",
"     <li>",
"      Lamisil (AR, AT, AU, BE, BG, BR, CH, CL, CN, CO, CZ, DK, EE, FI, FR, GB, GR, HK, HN, ID, IL, IT, KP, MY, NL, NO, PE, PH, PK, PL, PT, PY, RU, SE, SG, TH, TR, TW, UY);",
"     </li>",
"     <li>",
"      Lamisil AT (ID);",
"     </li>",
"     <li>",
"      Lamisil Once (AU, HK, PH, TH);",
"     </li>",
"     <li>",
"      Lamisilate (FR);",
"     </li>",
"     <li>",
"      Lan meishu (CL);",
"     </li>",
"     <li>",
"      Lisim (SG);",
"     </li>",
"     <li>",
"      Micoset (CN);",
"     </li>",
"     <li>",
"      Micozone (EC);",
"     </li>",
"     <li>",
"      Mujonal (CL);",
"     </li>",
"     <li>",
"      Mycelvan (DO, GT, PA, SV);",
"     </li>",
"     <li>",
"      Otenol (MY);",
"     </li>",
"     <li>",
"      Patir (IL);",
"     </li>",
"     <li>",
"      Periafin (TW);",
"     </li>",
"     <li>",
"      Ronasil Derm Gel (KP);",
"     </li>",
"     <li>",
"      Sebifin (IN);",
"     </li>",
"     <li>",
"      SolvEasy Tinea (AU, NZ);",
"     </li>",
"     <li>",
"      Terekol (AR);",
"     </li>",
"     <li>",
"      Terfex (VE);",
"     </li>",
"     <li>",
"      Terfine (TW);",
"     </li>",
"     <li>",
"      Terfung (TW);",
"     </li>",
"     <li>",
"      Tiersil Once (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F247707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Synthetic allylamine derivative which inhibits squalene epoxidase, a key enzyme in sterol biosynthesis in fungi. This results in a deficiency in ergosterol within the fungal cell wall and results in fungal cell death.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F247721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Limited (&lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Distributed to sebum and skin predominantly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Stratum corneum: ~27 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9924 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.167.4.114-B6D75EF485-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6900=[""].join("\n");
var outline_f6_47_6900=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9566190\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9566191\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9566196\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9568028\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9568027\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9568029\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247718\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10076341\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9566194\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247719\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9566186\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9568009\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9601565\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247709\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300113\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247713\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9568004\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9568007\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9572927\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961914\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247707\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F247721\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9924\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9924|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?33/35/34358?source=related_link\">",
"      Terbinafine (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?9/46/9957?source=related_link\">",
"      Terbinafine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/4/19526?source=related_link\">",
"      Terbinafine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?38/53/39763?source=related_link\">",
"      Terbinafine (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?1/30/1507?source=related_link\">",
"      Terbinafine (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_47_6901="Atorvastatin: Patient drug information";
var content_f6_47_6901=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Atorvastatin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"     see \"Atorvastatin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/59/21432?source=see_link\">",
"     see \"Atorvastatin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F137661\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lipitor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F137662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Atorvastatin&reg;;",
"     </li>",
"     <li>",
"      Ava-Atorvastatin;",
"     </li>",
"     <li>",
"      CO Atorvastatin;",
"     </li>",
"     <li>",
"      Dom-Atorvastatin;",
"     </li>",
"     <li>",
"      GD-Atorvastatin;",
"     </li>",
"     <li>",
"      Lipitor&reg;;",
"     </li>",
"     <li>",
"      Mylan-Atorvastatin;",
"     </li>",
"     <li>",
"      Novo-Atorvastatin;",
"     </li>",
"     <li>",
"      PMS-Atorvastatin;",
"     </li>",
"     <li>",
"      RAN&trade;-Atorvastatin;",
"     </li>",
"     <li>",
"      ratio-Atorvastatin;",
"     </li>",
"     <li>",
"      Sandoz-Atorvastatin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691456",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop heart attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop strokes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower cholesterol and other harmful types of cholesterol in the body. Good cholesterol (HDL) levels rise.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691358",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower triglycerides.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691638",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to slow the progress of heart disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701565",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to atorvastatin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703199",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Active liver disease or a rise in liver enzymes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696863",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 4 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid grapefruit and grapefruit juice.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid or limit drinking wine, beer, or mixed drinks to less than 3 drinks a day. Drinking too much alcohol may raise your chance of liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698255",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698663",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11577 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-C0B5FDA9AB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6901=[""].join("\n");
var outline_f6_47_6901=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137661\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137662\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022614\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022616\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022615\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022620\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022621\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022623\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022618\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022619\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022624\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022625\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=related_link\">",
"      Atorvastatin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/59/21432?source=related_link\">",
"      Atorvastatin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_47_6902="Ovarian transposition before pelvic radiation";
var content_f6_47_6902=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ovarian transposition before pelvic radiation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/47/6902/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6902/contributors\">",
"     Togas Tulandi, MD, MHCM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/47/6902/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6902/contributors\">",
"     Tommaso Falcone, MD, FRCSC, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/47/6902/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6902/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/47/6902/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H30824440\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oocytes are uniquely sensitive to radiation injury. A mathematical model predicted 16 gray (Gy) of radiation would deplete the ovarian oocyte pool at age 20 years and 10 Gy of radiation would deplete the ovarian oocyte pool at age 45 years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/1\">",
"     1",
"    </a>",
"    ]. One method of protecting the ovaries from radiation injury is to transpose them out of the radiation field (ie, ovarian transposition, also known as ovarian suspension, oophoropexy, or ovariopexy) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The vascular pedicle remains intact in ovarian transposition, which distinguishes this procedure from ovarian transplantation.",
"   </p>",
"   <p>",
"    Historically, the ovaries were relocated medially by suturing them to the posterior uterus, and protected during radiation therapy with a lead shield placed centrally on the abdomen [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/4\">",
"     4",
"    </a>",
"    ]. However, medially placed ovaries still absorb radiation from scatter and some transmission through the shield, reducing the efficacy of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Contemporary procedures transpose the ovaries above the pelvic brim and as lateral as possible, which minimizes the ovarian dose of radiation and improves efficacy compared with medial approaches. Various lateral locations have been used, including the base of the round ligament [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/8\">",
"     8",
"    </a>",
"    ], the level of lower kidney pole [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/9\">",
"     9",
"    </a>",
"    ], and the paracolic gutters [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11178564\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian transposition is performed to preserve fertility or prevent early menopause in reproductive aged women who are undergoing pelvic or low abdominal radiation therapy and who will be treated with chemotherapy with low probability of gonadotoxicity (",
"    <a class=\"graphic graphic_table graphicRef58142 \" href=\"UTD.htm?5/18/5421\">",
"     table 1",
"    </a>",
"    ). In our institution, the most common cancers in adults treated with low abdominal radiation are rectal and anal. These cancers are usually also treated with 5-fluorouracil (5FU) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/16/38144?source=see_link\">",
"     mitomycin",
"    </a>",
"    , which are not gonadotoxic, thus these patients are candidates for ovarian transposition. In children, Hodgkin or non-Hodgkin lymphoma, vaginal or uterine tumors, pelvic Ewing's sarcoma, and spinal tumors are more common reasons for referral for the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The decision to perform ovarian transposition depends on a combination of factors including the patient&rsquo;s age, ovarian reserve, desire for future pregnancy, personal preferences (eg, willingness to take hormone therapy for premature menopause), medical condition, and prognosis. The patient&rsquo;s medical team (medical and radiation oncologists, reproductive endocrinologist, and surgeon who will perform the transposition) should help the patient weigh the risks and benefits of ovarian transposition based on her specific clinical situation.",
"   </p>",
"   <p>",
"    The potential benefit of the procedure is lower in older women and women at increased risk of ovarian metastases:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Menopausal women are not candidates for ovarian transposition, as the benefits of protecting postmenopausal ovarian function are minimal. &nbsp;",
"     </li>",
"     <li>",
"      Women over 40 years old are not good candidates for transposition because they generally have reduced fertilization potential and are a high risk for ovarian failure even with the procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/12,16\">",
"       12,16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Women with cancers at moderate or high risk for ovarian metastasis may not be good candidates for ovarian preservation and, in turn, ovarian transposition. Cancers at high risk of ovarian metastasis include leukemia, neuroblastoma, and Burkitt lymphoma; moderate risk cancers include",
"      <span class=\"nowrap\">",
"       adenocarcinoma/adenosquamous",
"      </span>",
"      carcinoma of the cervix, squamous cell cervical cancer &gt;3 cm in diameter or &gt;stage Ib1 [",
"      <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/17\">",
"       17",
"      </a>",
"      ], colon cancer, stage IV breast cancer,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      infiltrative lobular breast cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30824461\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION AND COUNSELING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women whose primary objective is fertility preservation should be referred to a reproductive",
"    <span class=\"nowrap\">",
"     endocrinologist/reproductive",
"    </span>",
"    surgeon to assess ovarian reserve and discuss their options for fertility preservation. Embryo cryopreservation is the most effective method of fertility preservation; mature oocyte cryopreservation is also effective and is a good option if no sperm are available for fertilization prior to cryopreservation. These procedures can be performed in addition to, or instead of, ovarian transposition, depending on the time and resources available before the start of cancer therapy. Retrieval of immature oocytes followed by in vitro maturation and vitrification is a good method of obtaining oocytes when it is not advisable for the patient to undergo ovulation induction, but it is an investigational procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/19\">",
"     19",
"    </a>",
"    ]. Ovarian tissue cryopreservation is another option, but it is also an investigational procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=see_link\">",
"     \"Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For women over 35 years of age and younger women with risk factors for premature ovarian failure, ovarian reserve should be evaluated. However, no test is highly reliable in predicting fertility potential. The author measures basal serum follicle-stimulating hormone (FSH) (on cycle day 3 if possible) and anti-m&uuml;llerian hormone (AMH) levels and antral follicle count (AFC). AMH is most useful when time is limited because it can be measured anytime during the menstrual cycle. A menopausal level of FSH (&gt;40",
"    <span class=\"nowrap\">",
"     IU/L)",
"    </span>",
"    strongly suggests that the procedure will be futile for preserving fertility. High FSH (&gt;10 to 25",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    on cycle day 3, the cut-off is highly laboratory dependent), low AMH (&lt;0.15",
"    <span class=\"nowrap\">",
"     ng/mL),",
"    </span>",
"    and low AFC (4 to 10 antral follicles usually measured between days 2 and 4 of a regular menstrual cycle) indicate poor ovarian reserve, suggesting poor fertility potential. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/61/40921?source=see_link&amp;anchor=H9#H9\">",
"     \"Evaluation of female infertility\", section on 'Assessment of ovarian reserve'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30824468\">",
"    <span class=\"h1\">",
"     PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Good communication is crucial among the treatment team (medical and radiation oncologists, reproductive endocrinologist, and surgeon performing the transposition). Before surgery, the radiation oncologist should outline the field of radiation on the abdominal wall so the surgeon can determine the best location of transposition.",
"   </p>",
"   <p>",
"    Ovarian transposition can be performed by laparotomy or laparoscopy; outcomes are similar for both approaches [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. For patients who are not already undergoing laparotomy for primary treatment of their disease (eg, open radical hysterectomy for cervical cancer), laparoscopy is the preferred approach. The minimally invasive procedure has fewer complications and a shorter healing time than laparotomy, allowing earlier initiation of radiation therapy. Radiation can be started within a day or two following laparoscopy.",
"   </p>",
"   <p>",
"    We retrieve immature oocytes under transvaginal ultrasound guidance, as well as at laparoscopy before ovarian transposition. In young girls, immature oocytes can only be harvested at laparoscopy.",
"   </p>",
"   <p>",
"    The key steps of the procedure are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary trocar is inserted cephalad from the upper margin of the radiation field usually 2 to 3 cm above the umbilicus. This facilitates relocation of the ovaries as high as possible.",
"     </li>",
"     <li>",
"      Two secondary trocars are placed at the same level or slightly lower.",
"     </li>",
"     <li>",
"      The abdominal cavity is thoroughly examined, including the liver and diaphragm. We perform peritoneal lavage for cytologic examination, although there is no evidence supporting its use routinely.",
"     </li>",
"     <li>",
"      If oocyte retrieval is planned for oocyte or embryo cryopreservation, an oocyte retrieval needle is used to aspirate all visible follicles. If ovarian cryopreservation is planned, we perform a unilateral ovarian wedge resection or occasionally a unilateral oophorectomy. The decision is based on the patient&rsquo;s preference. Appropriate personnel and laboratory facilities must be available to process these specimens. Before processing the ovarian wedge specimen, the embryologist makes another attempt to retrieve oocytes from all visible follicles in the ovarian tissue.",
"     </li>",
"     <li>",
"      The course of each ureter is identified.",
"     </li>",
"     <li>",
"      The utero-ovarian ligament and vessels on each side are divided and the mesovarium on each side is opened (",
"      <a class=\"graphic graphic_figure graphicRef87821 \" href=\"UTD.htm?31/8/31872\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The remaining mesovarium is incised to the infundibulopelvic ligament, leaving the vascular pedicle inside the ligament intact.",
"     </li>",
"     <li>",
"      The ovaries are mobilized to a level cephalad to the anterior superior iliac spine without tension [",
"      <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/22\">",
"       22",
"      </a>",
"      ]. To provide sufficient mobilization, the peritoneum along the infundibulopelvic ligament is incised above the ureter and as far as the aortic bifurcation or paracolic gutter. If mobilization remains inadequate, the fallopian tubes are transected (",
"      <a class=\"graphic graphic_picture graphicRef87822 \" href=\"UTD.htm?20/18/20773\">",
"       picture 1",
"      </a>",
"      ); however, in most cases, they can be left intact, facilitating future spontaneous conception [",
"      <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      After ensuring that the ovarian blood supply is not kinked or compromised, the transposed ovaries are sutured securely to the peritoneum lateral to the intraabdominal or lower paracolic gutters, close to the lateral aspect of the colon near the level of the iliac fossa, using non-absorbable sutures.",
"     </li>",
"     <li>",
"      The lateral opening in the broad ligament caudal to the newly located ovaries is closed with a few sutures to prevent herniation.",
"     </li>",
"     <li>",
"      Surgical hemoclips are applied to the border of each ovary to help the radiation oncologist identify the site of the transposed ovaries.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30824475\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of ovarian transposition are rare and include reports of injury and torsion of the ovarian blood vessels resulting in vascular ovarian injury, chronic ovarian pain, and infarction of the fallopian tube [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/4,5,21,23,24\">",
"     4,5,21,23,24",
"    </a>",
"    ]. Ovarian cyst formation is described more commonly (incidence 0 to 23 percent), but may be unrelated to the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/23,25\">",
"     23,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4286831\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30824482\">",
"    <span class=\"h2\">",
"     Ovarian function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The purpose of ovarian transposition is to protect the ovaries from radiation and thus preserve endocrine function and fertility. Most of the data on reproductive function after ovarian transposition are based on case reports or small case series. In one review of the literature, laparoscopic ovarian transposition in women younger than 40 years was associated with preservation of ovarian function in 39 of 44 patients (88.6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a series of 95 patients with cervical cancer, ovarian transposition in conjunction with radical hysterectomy was associated with preservation of ovarian function in 90 percent of patients treated by postoperative vaginal brachytherapy and 60 percent of patients treated by postoperative external radiation therapy and vaginal brachytherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/16\">",
"     16",
"    </a>",
"    ]. Ovarian function was considered normally preserved when the follicle-stimulating hormone (FSH) level was &lt;10",
"    <span class=\"nowrap\">",
"     mIU/mL,",
"    </span>",
"    E2 was &gt;50",
"    <span class=\"nowrap\">",
"     pg/mL,",
"    </span>",
"    and when follicles were present on the ultrasound scan.",
"   </p>",
"   <p>",
"    The uterus is less sensitive to radiation therapy than the ovaries, but may be affected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7977?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of fertility and pregnancy in cancer survivors\", section on 'Radiation therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30824496\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy rates depend on many factors, including age, type of cancer treatment, and underlying infertility factors. The following studies are examples of the available data:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study of 11 girls with Hodgkin lymphoma who underwent bilateral ovarian transposition at a median age of 13 years reported 14 pregnancies (12 live births [one twin] and 3 miscarriages) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 37 consecutive patients who underwent ovarian transposition with uterine conservation and pelvic irradiation therapy for pelvic cancer, the overall pregnancy rate was",
"      <span class=\"nowrap\">",
"       12/37",
"      </span>",
"      (32 percent); a total of 18 pregnancies were achieved among the 12 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/27\">",
"       27",
"      </a>",
"      ]. When the results were analyzed by diagnosis (group 1:27 women with clear cell adenocarcinoma of the vagina",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the cervix; group 2: 9 women with ovarian dysgerminoma and 1 woman with uterine sarcoma), the pregnancy rate was lower in group 1 (15 versus 80 percent). The authors hypothesized the low pregnancy rate in group 1 may be related to diethylstilbestrol-related anomalies of the reproductive tract in addition to brachytherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/17\">",
"       17",
"      </a>",
"      ]. However, there were other differences between groups; for example, more patients in group 1 received brachytherapy",
"      <span class=\"nowrap\">",
"       (27/27",
"      </span>",
"      versus",
"      <span class=\"nowrap\">",
"       0/10).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In women who undergo hysterectomy, surrogate pregnancy is possible using oocytes retrieved from the transposed ovaries; several successful cases have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6902/abstract/28-31\">",
"     28-31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15015?source=see_link\">",
"     \"Surrogate pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30825127\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ovarian transposition is performed to preserve fertility or prevent early menopause in reproductive aged women who are undergoing pelvic or low abdominal radiation therapy and who will not be treated with gonadotoxic chemotherapy (",
"      <a class=\"graphic graphic_table graphicRef58142 \" href=\"UTD.htm?5/18/5421\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11178564\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Menopausal women are not candidates for ovarian transposition. Women over 40 years old with poor ovarian reserve and women with cancers at moderate or high risk for ovarian metastasis in whom ovarian preservation is contraindicated are not good candidates for the procedure. (See",
"      <a class=\"local\" href=\"#H11178564\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who are not already undergoing laparotomy for primary treatment of their disease, laparoscopy is the preferred approach and allows early initiation of radiation therapy. (See",
"      <a class=\"local\" href=\"#H30824468\">",
"       'Procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If oocyte or embryo cryopreservation is planned, all visible follicles are aspirated at the time of the procedure. If ovarian cryopreservation is planned, we perform a unilateral ovarian wedge resection or occasionally unilateral oophorectomy. (See",
"      <a class=\"local\" href=\"#H30824461\">",
"       'Preoperative evaluation and counseling'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H30824468\">",
"       'Procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laparoscopic ovarian transposition has low complication rates and ovarian function is preserved in most patients. In women who also undergo hysterectomy, surrogate pregnancy is possible using oocytes retrieved from the transposed ovaries. (See",
"      <a class=\"local\" href=\"#H4286831\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6594810\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and UpToDate would like to acknowledge William J Mann, Jr, MD and Fidel A Valea, MD, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/1\">",
"      Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005; 62:738.",
"     </a>",
"    </li>",
"    <li>",
"     Al-Talib A, Nezhat F, Tulandi T. Fertility Preservation in Women with Gynaecological Cancer. Eur J Obstet Gynecol 2009; 4:35.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/3\">",
"      Tulandi T, Huang JY, Tan SL. Preservation of female fertility: an essential progress. Obstet Gynecol 2008; 112:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/4\">",
"      Gabriel DA, Bernard SA, Lambert J, Croom RD 3rd. Oophoropexy and the management of Hodgkin's disease. A reevaluation of the risks and benefits. Arch Surg 1986; 121:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/5\">",
"      Williams RS, Littell RD, Mendenhall NP. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer 1999; 86:2138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/6\">",
"      Ray GR, Trueblood HW, Enright LP, et al. Oophoropexy: a means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin's disease. Radiology 1970; 96:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/7\">",
"      Hadar H, Loven D, Herskovitz P, et al. An evaluation of lateral and medial transposition of the ovaries out of radiation fields. Cancer 1994; 74:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/8\">",
"      Lee CL, Lai YM, Soong YK, et al. Laparoscopic ovariopexy before irradiation for medulloblastoma. Hum Reprod 1995; 10:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/9\">",
"      Schulz-Lobmeyr I, Schratter-Sehn A, Huber J, Wenzl R. Laparoscopic lateral ovarian transposition before pelvic irradiation for a Non Hodgkin lymphoma. Acta Obstet Gynecol Scand 1999; 78:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/10\">",
"      Covens AL, van der Putten HW, Fyles AW, et al. Laparoscopic ovarian transposition. Eur J Gynaecol Oncol 1996; 17:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/11\">",
"      Yarali H, Demirol A, B&uuml;k&uuml;lmez O, et al. Laparoscopic high lateral transposition of both ovaries before pelvic irradiation. J Am Assoc Gynecol Laparosc 2000; 7:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/12\">",
"      Clough KB, Goffinet F, Labib A, et al. Laparoscopic unilateral ovarian transposition prior to irradiation: prospective study of 20 cases. Cancer 1996; 77:2638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/13\">",
"      Thibaud E, Ramirez M, Brauner R, et al. Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr 1992; 121:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/14\">",
"      Cuny A, Trivin C, Brailly-Tabard S, et al. Inhibin B and anti-M&uuml;llerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood. J Pediatr 2011; 158:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/15\">",
"      Lawrenz B, Jauckus J, Kupka MS, et al. Fertility preservation in &gt;1,000 patients: patient's characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet 2011; 283:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/16\">",
"      Morice P, Juncker L, Rey A, et al. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 2000; 74:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/17\">",
"      Morice P, Haie-Meder C, Pautier P, et al. Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications. Gynecol Oncol 2001; 83:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/18\">",
"      Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004; 10:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/19\">",
"      Moria A, Das M, Shehata F, et al. Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment. Fertil Steril 2011; 95:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/20\">",
"      Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol 2003; 188:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/21\">",
"      Husseinzadeh N, Nahhas WA, Velkley DE, et al. The preservation of ovarian function in young women undergoing pelvic radiation therapy. Gynecol Oncol 1984; 18:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/22\">",
"      Hwang JH, Yoo HJ, Park SH, et al. Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril 2012; 97:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/23\">",
"      Anderson B, LaPolla J, Turner D, et al. Ovarian transposition in cervical cancer. Gynecol Oncol 1993; 49:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/24\">",
"      Morice P, Castaigne D, Haie-Meder C, et al. Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertil Steril 1998; 70:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/25\">",
"      Pahisa J, Mart&iacute;nez-Rom&aacute;n S, Mart&iacute;nez-Zamora MA, et al. Laparoscopic ovarian transposition in patients with early cervical cancer. Int J Gynecol Cancer 2008; 18:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/26\">",
"      Terenziani M, Piva L, Meazza C, et al. Oophoropexy: a relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril 2009; 91:935.e15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/27\">",
"      Morice P, Thiam-Ba R, Castaigne D, et al. Fertility results after ovarian transposition for pelvic malignancies treated by external irradiation or brachytherapy. Hum Reprod 1998; 13:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/28\">",
"      Agorastos T, Zafrakas M, Mastrominas M. Long-term follow-up after cervical cancer treatment and subsequent successful surrogate pregnancy. Reprod Biomed Online 2009; 19:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/29\">",
"      Steigrad S, Hacker NF, Kolb B. In vitro fertilization surrogate pregnancy in a patient who underwent radical hysterectomy followed by ovarian transposition, lower abdominal wall radiotherapy, and chemotherapy. Fertil Steril 2005; 83:1547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/30\">",
"      Azem F, Yovel I, Wagman I, et al. Surrogate pregnancy in a patient who underwent radical hysterectomy and bilateral transposition of ovaries. Fertil Steril 2003; 79:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6902/abstract/31\">",
"      Zinger M, Liu JH, Husseinzadeh N, Thomas MA. Successful surrogate pregnancy after ovarian transposition, pelvic irradiation and hysterectomy. J Reprod Med 2004; 49:573.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3294 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-C801F8800B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6902=[""].join("\n");
var outline_f6_47_6902=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30825127\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30824440\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11178564\">",
"      PATIENT SELECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30824461\">",
"      PREOPERATIVE EVALUATION AND COUNSELING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30824468\">",
"      PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30824475\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4286831\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30824482\">",
"      Ovarian function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30824496\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30825127\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6594810\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/3294\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3294|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/8/31872\" title=\"figure 1\">",
"      Initiation of ovarian transposition procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3294|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/18/20773\" title=\"picture 1\">",
"      Transected utero-ovarian ligament and fallopian tube",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3294|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/18/5421\" title=\"table 1\">",
"      Ovarian failure anticancer Rx",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/61/40921?source=related_link\">",
"      Evaluation of female infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=related_link\">",
"      Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7977?source=related_link\">",
"      Overview of fertility and pregnancy in cancer survivors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15015?source=related_link\">",
"      Surrogate pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_47_6903="Phenylephrine (systemic): Drug information";
var content_f6_47_6903=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Phenylephrine (systemic): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?32/59/33717?source=see_link\">",
"    see \"Phenylephrine (systemic): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/23/13686?source=see_link\">",
"    see \"Phenylephrine (systemic): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F9504748\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9504766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Medi-First&reg; Sinus Decongestant [OTC];",
"     </li>",
"     <li>",
"      Medi-Phenyl [OTC];",
"     </li>",
"     <li>",
"      PediaCare&reg; Children's Decongestant [OTC];",
"     </li>",
"     <li>",
"      Sudafed PE&reg; Children's [OTC];",
"     </li>",
"     <li>",
"      Sudafed PE&reg; Congestion [OTC];",
"     </li>",
"     <li>",
"      Sudafed PE&trade; Nasal Decongestant [OTC];",
"     </li>",
"     <li>",
"      Sudogest&trade; PE [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9508672\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Alpha-Adrenergic Agonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9504918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypotension/shock:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V. bolus:",
"     </i>",
"     100-500 mcg/dose every 10-15 minutes as needed (initial dose should not exceed 500 mcg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V. infusion:",
"     </i>",
"     Initial dose: 100-180 mcg/minute,",
"     <b>",
"      or alternatively",
"     </b>",
"     , 0.5 mcg/kg/minute; titrate to desired response. Dosing ranges between 0.4-9.1 mcg/kg/minute have been reported when treating septic shock (Gregory, 1991).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nasal congestion:",
"     </b>",
"     <i>",
"      Oral:",
"     </i>",
"     OTC labeling: 10 mg every 4 hours as needed for &le;7 days (maximum: 60 mg/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Paroxysmal supraventricular tachycardia (Note: Not recommended for routine use in treatment of supraventricular tachycardias):",
"     </b>",
"     <i>",
"      I.V.:",
"     </i>",
"     250-500 mcg/dose over 20-30 seconds",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9504917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/23/13686?source=see_link\">",
"      see \"Phenylephrine (systemic): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypotension/shock:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V. bolus:",
"     </i>",
"     5-20 mcg/kg/dose every 10-15 minutes as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V. infusion:",
"     </i>",
"     0.1-0.5 mcg/kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nasal congestion:",
"     </b>",
"     <i>",
"      Oral:",
"     </i>",
"     OTC labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4 to &lt;6 years: 2.5 mg every 4 hours as needed for &le;7 days (maximum: 15 mg/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     6 to &lt;12 years: 5 mg every 4 hours as needed for &le;7 days (maximum: 30 mg/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Paroxysmal supraventricular tachycardia (Note: Not recommended for routine use in treatment of supraventricular tachycardias):",
"     </b>",
"     <i>",
"      I.V.:",
"     </i>",
"     5-10 mcg/kg/dose over 20-30 seconds",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F9504919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9505013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 1% [10 mg/mL] (1 mL, 5 mL, 10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PediaCare&reg; Children's Decongestant: 2.5 mg/5 mL (118 mL) [contains sodium 14 mg/5 mL, sodium benzoate; raspberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sudafed PE&reg; Children's: 2.5 mg/5 mL (118 mL) [ethanol free, sugar free; contains sodium 14 mg/5 mL, sodium benzoate; raspberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Medi-First&reg; Sinus Decongestant: 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Medi-Phenyl: 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sudafed PE&reg; Congestion: 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sudafed PE&trade; Nasal Decongestant: 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sudogest&trade; PE: 10 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9504775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes liquid",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9504945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     I.V.: May cause necrosis or sloughing tissue if extravasation occurs during I.V. administration or SubQ administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Extravasation management:",
"     </b>",
"     Use phentolamine as antidote; mix 5-10 mg with 10 mL of NS. Inject a small amount of this dilution subcutaneously into extravasated area. Blanching should reverse immediately. Monitor site. If blanching should recur, additional injections of phentolamine may be needed.",
"    </p>",
"   </div>",
"   <div class=\"block uica drugH1Div\" id=\"F14473053\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Usual Infusion Concentrations: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      I.V. infusion:",
"     </b>",
"     10 mg in 500 mL (concentration: 20",
"     <b>",
"      mcg",
"     </b>",
"     /mL) of D",
"     <sub>",
"      5",
"     </sub>",
"     W or NS, 50 mg in 500 mL (concentration: 100",
"     <b>",
"      mcg",
"     </b>",
"     /mL) of NS,",
"     <b>",
"      or",
"     </b>",
"     100 mg in 500 mL (concentration: 200",
"     <b>",
"      mcg",
"     </b>",
"     /mL) of NS",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Other institutions may use concentrations of 40",
"     <b>",
"      mcg",
"     </b>",
"     /mL",
"     <b>",
"      or",
"     </b>",
"     160",
"     <b>",
"      mcg",
"     </b>",
"     /mL; however, stability information is not available for these concentrations.",
"    </p>",
"   </div>",
"   <div class=\"block uicp drugH1Div\" id=\"F14473054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Usual Infusion Concentrations: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      I.V. infusion:",
"     </b>",
"     20",
"     <b>",
"      mcg",
"     </b>",
"     /mL, 40",
"     <b>",
"      mcg",
"     </b>",
"     /mL, or 60",
"     <b>",
"      mcg",
"     </b>",
"     /mL",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F9504868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     R, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR, R,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS, sodium bicarbonate 5%.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amiodarone, anidulafungin, argatroban, bivalirudin, caffeine citrate, caspofungin, cisatracurium, doripenem, ethyl alcohol, etomidate, famotidine, fenoldopam, haloperidol, hetastarch in lactate electrolyte injection (Hextend&reg;), inamrinone, levofloxacin, micafungin, potassium chloride, remifentanil, telavancin, vasopressin, zidovudine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Thiopental.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Furosemide, nesiritide, propofol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Caffeine citrate.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F9504776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of hypotension, vascular failure in shock; as a vasoconstrictor in regional analgesia; supraventricular tachycardia (",
"     <b>",
"      Note:",
"     </b>",
"     Not for routine use in treatment of supraventricular tachycardias); as a decongestant [OTC]",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9504764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Sudafed PE&reg; may be confused with Sudafed&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9504821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Injection:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia (rare), decreased cardiac output, hypertension, pallor, precordial pain or discomfort, reflex bradycardia, severe peripheral and visceral vasoconstriction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Anxiety, dizziness, excitability, giddiness, headache, insomnia, nervousness, restlessness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Metabolic acidosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Gastric irritation, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: I.V.: Extravasation which may lead to necrosis and sloughing of surrounding tissue, blanching of skin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia, pilomotor response, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Decreased renal perfusion, reduced urine output",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Respiratory distress",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity reactions (including rash, urticaria, leukopenia, agranulocytosis, thrombocytopenia)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Oral:",
"     </b>",
"     Central nervous system: Anxiety, dizziness, excitability, giddiness, headache, insomnia, nervousness, restlessness",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F9504781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to phenylephrine or any component of the formulation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection: Severe hypertension; ventricular tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Use with or within 14 days of MAO inhibitor therapy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9504782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Monoamine oxidase inhibitors (MAO-I): Use with extreme caution in patients taking MAO inhibitors; hypertension may result from concurrent use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Intravenous: Use with caution in the elderly, patients with hyperthyroidism, bradycardia, partial heart block, myocardial disease, or severe CAD. Avoid or use with extreme caution in patients with heart failure or cardiogenic shock; increased systemic vascular resistance may significantly reduce cardiac output. Assure adequate circulatory volume to minimize need for vasoconstrictors. Avoid use in patients with hypertension (contraindicated in severe hypertension); monitor blood pressure closely and adjust infusion rate. Avoid extravasation; infuse into a large vein if possible. Avoid infusion into leg veins. Watch I.V. site closely. If extravasation occurs, infiltrate the area subcutaneously with diluted phentolamine (5-10 mg in 10 mL of saline) with a fine hypodermic needle.",
"     <b>",
"      Phentolamine should be administered as soon as possible after extravasation is noted.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Oral: When used for self-medication (OTC), use with caution in patients with asthma, bowel obstruction/narrowing, hyperthyroidism, diabetes mellitus, cardiovascular disease, ischemic heart disease, hypertension, increased intraocular pressure, prostatic hyperplasia or in the elderly. Notify healthcare provider if symptoms do not improve within 7 days or are accompanied by fever. Discontinue and contact healthcare provider if nervousness, dizziness, or sleeplessness occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfites: Some products contain sulfites which may cause allergic reactions in susceptible individuals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Trained personnel:",
"     <b>",
"      [U.S. Boxed Warning]: Intravenous preparations should be administered by adequately trained individuals familiar with its use.",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299870\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9504824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May diminish the hypertensive effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize hypotensive effects of Alpha1-Blockers. Alpha1-Blockers may diminish the vasoconstricting effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize Alpha1-Blocker vasodilation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Alpha1-Agonists may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Consider use of a histamine skin test as a positive control to assess a patient's ability to mount a wheal and flare response.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: May enhance the hypertensive effect of Alpha1-Agonists. Ergot Derivatives may enhance the vasoconstricting effect of Alpha1-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ergoloid Mesylates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: Alpha1-Agonists may decrease the serum concentration of FentaNYL. Specifically, fentanyl nasal spray serum concentrations may decrease and onset of effect may be delayed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: May enhance the vasoconstricting effect of Phenylephrine (Systemic). Management: Avoid the use of hyaluronidase to enhance dispersion or absorption of phenylephrine.  Use of hyaluronidase for other purposes in patients receiving phenylephrine may be considered as clinically indicated.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypertensive effect of Alpha1-Agonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May enhance the vasopressor effect of Alpha1-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F9504828\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Herb/Nutraceutical: Avoid ephedra, yohimbe (may cause CNS stimulation).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F9504777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9504778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted; therefore, the manufacturer classifies phenylephrine as pregnancy category C. Phenylephrine crosses the placenta at term. Maternal use of phenylephrine during the first trimester of pregnancy is not strongly associated with an increased risk of fetal malformations; maternal dose and duration of therapy were not reported in available publications. Phenylephrine is available over-the-counter (OTC) for the symptomatic relief of nasal congestion. Decongestants are not the preferred agents for the treatment of rhinitis during pregnancy. Oral phenylephrine should be avoided during the first trimester of pregnancy; short-term use (&lt;3 days) of intranasal phenylephrine may be beneficial to some patients although its safety during pregnancy has not been studied. Phenylephrine injection is used at delivery for the prevention and/or treatment of maternal hypotension associated with spinal anesthesia in women undergoing cesarean section. Phenylephrine may be associated with a more favorable fetal acid base status than ephedrine; however, overall fetal outcomes appear to be similar. Nausea or vomiting may be less with phenylephrine than ephedrine but is also dependent upon blood pressure control. Phenylephrine may be preferred in the absence of maternal bradycardia.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F9504780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F11393286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if phenylephrine is excreted into breast milk. The manufacturer recommends that caution be exercised when administering phenylephrine to nursing women.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F9504944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Some products may contain phenylalanine and/or sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Lusonal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7.5 mg/5 mL (473 mL): $68.01",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (PediaCare Childrens Decongest Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg/5 mL (118 mL): $5.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Sudafed PE Childrens Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg/5 mL (118 mL): $5.51",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Contac-D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (24): $4.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Medi-Phenyl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (2): $0.14",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Sudafed PE Maximum Strength Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (18): $4.49",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Sudogest PE Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (18): $3.79",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F9504948\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure (or mean arterial pressure), heart rate; cardiac output (as appropriate), intravascular volume status, pulmonary capillary wedge pressure (as appropriate); monitor infusion site closely",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10961999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Fadalefrina (AR, UY);",
"     </li>",
"     <li>",
"      Fenylefrinhydroklorid (NO);",
"     </li>",
"     <li>",
"      Metaoxedrin (DK);",
"     </li>",
"     <li>",
"      Neo-Synephrine (AU, PH);",
"     </li>",
"     <li>",
"      We Li Ang (CL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F9504869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Potent, direct-acting alpha-adrenergic agonist with virtually no beta-adrenergic activity; produces systemic arterial vasoconstriction. Such increases in systemic vascular resistance result in dose dependent increases in systolic and diastolic blood pressure and reductions in heart rate and cardiac output especially in patients with heart failure.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F9504889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Blood pressure increase/vasoconstriction: I.M., SubQ: 10-15 minutes; I.V.: Immediate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nasal decongestant: Oral: 15-30 minutes (Kollar, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Blood pressure increase/vasoconstriction: I.M.: 1-2 hours; I.V.: ~15-20 minutes; SubQ: 50 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nasal decongestant: Oral: &le;4 hours (Kollar, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Rapid and complete (Kanfer, 1993)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Initial: 26-61 L; V",
"     <sub>",
"      dss",
"     </sub>",
"     : 184-543 L (mean: 340 L) (Hengstmann, 1982)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via oxidative deamination (Oral: 24%; I.V.: 50%); Undergoes sulfation (Oral [mostly within gut wall]: 46%; I.V.: 8%) and some glucuronidation; forms inactive metabolites (Kanfer, 1993)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: &le;38% (Hengstmann, 1982; Kanfer, 1993)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Alpha phase: ~5 minutes; Terminal phase: 2-3 hours (Hengstmann, 1982; Kanfer, 1993)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: Oral: 0.75-2 hours (Kanfer, 1993)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (mostly as inactive metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Beale RJ, Hollenberg SM, Vincent JL, et al, &ldquo;Vasopressor and Inotropic Support in Septic Shock: An Evidence Based Review,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2004, 32(11 Suppl):455-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/15542956/pubmed\" id=\"15542956\" target=\"_blank\">",
"        15542956",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bonfiglio MF, Dasta JF, Gregory JS, et al, &ldquo;High-Dose Phenylephrine Infusion in the Hemodynamic Support of Septic Shock,&rdquo;",
"      <i>",
"       DICP",
"      </i>",
"      , 1990, 24(10):936-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/2244407/pubmed\" id=\"2244407\" target=\"_blank\">",
"        2244407",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dellinger RP, Levy MM, Carlet JM, et al, &ldquo;Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008,&rdquo; [published correction appears in",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2008, 36(4):1394-6],",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2008, 36(1):296-327.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/18158437/pubmed\" id=\"18158437\" target=\"_blank\">",
"        18158437",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dellinger RP, Levy MM, Rhodes A, et al, &ldquo;Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2013, 41(2):580-637.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/23353941/pubmed\" id=\"23353941\" target=\"_blank\">",
"        23353941",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Flancbaum L, Dick M, Dasta J, et al, &ldquo;A Dose-Response Study of Phenylephrine in Critically Ill, Septic Surgical Patients,&rdquo;",
"      <i>",
"       Eur J Clin Pharmacol",
"      </i>",
"      , 1997, 51(6):461-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/9112060/pubmed\" id=\"9112060\" target=\"_blank\">",
"        9112060",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goertz AW, Lindner KH, Seefelder C, et al, &ldquo;Effect of Phenylephrine Bolus Administration on Global Left Ventricular Function in Patients With Coronary Artery Disease and Patients With Valvular Aortic Stenosis,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1993, 78(5):834-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/8489054/pubmed\" id=\"8489054\" target=\"_blank\">",
"        8489054",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gregory JS, Bonfiglio MF, Dasta JF, et al, &ldquo;Experience With Phenylephrine as a Component of the Pharmacologic Support of Septic Shock,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 1991, 19(11):1395-400.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/1935160/pubmed\" id=\"1935160\" target=\"_blank\">",
"        1935160",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gupta VD, &ldquo;Chemical Stability of Phenylephrine Hydrochloride After Reconstitution in 0.9% Sodium Chloride Injection for Infusion,&rdquo;",
"      <i>",
"       Int J Pharmaceut Compound",
"      </i>",
"      , 2004, 8(2):153-5",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hengstmann JH and Goronzy J, &ldquo;Pharmacokinetics of 3H-Phenylephrine in Man,&rdquo;",
"      <i>",
"       Eur J Clin Pharmacol",
"      </i>",
"      , 1982, 21(4):335-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/7056280/pubmed\" id=\"7056280\" target=\"_blank\">",
"        7056280",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hollenberg SM, Ahrens TS, Annane D, et al, &ldquo;Practice Parameters for Hemodynamic Support of Sepsis in Adult Patients: 2004 Update,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2004, 32(9):1928-48.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/15343024/pubmed\" id=\"15343024\" target=\"_blank\">",
"        15343024",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kanfer I, Dowse R, and Vuma V, &ldquo;Pharmacokinetics of Oral Decongestants,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1993, 13(6 Pt 2):116-28; discussion 143-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/7507589/pubmed\" id=\"7507589\" target=\"_blank\">",
"        7507589",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kollar C, Schneider H, Waksman J, et al, &ldquo;Meta-Analysis of the Efficacy of  Single Dose of Phenylephrine 10 Mg Compared With Placebo in Adults With Acute Nasal Congestion Due to the Common Cold,&rdquo;",
"      <i>",
"       Clin Ther",
"      </i>",
"      , 2007, 29(6):1057-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/17692721/pubmed\" id=\"17692721\" target=\"_blank\">",
"        17692721",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Phillips MS, &ldquo;Standardizing I.V. Infusion Concentrations: National Survey Results,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2011, 68(22):2176-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/22058104/pubmed\" id=\"22058104\" target=\"_blank\">",
"        22058104",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weber CR and Gupta VD, &ldquo;Stability of Phenylephrine Hydrochloride in Intravenous Solutions,&rdquo;",
"      <i>",
"       J Hosp Pharm",
"      </i>",
"      , 1970, 28:200-8.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yamazaki T, Shimada Y, Taenaka N, et al, &ldquo;Circulatory Responses to Afterloading with Phenylephrine in Hyperdynamic Sepsis,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 1982,  10(7):432-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/47/6903/abstract-text/7083867/pubmed\" id=\"7083867\" target=\"_blank\">",
"        7083867",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9900 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-1FFB8D27E6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6903=[""].join("\n");
var outline_f6_47_6903=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504748\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504766\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9508672\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504918\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504917\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504919\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9505013\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504775\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504945\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14473053\">",
"      Usual Infusion Concentrations: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14473054\">",
"      Usual Infusion Concentrations: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504868\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504776\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504764\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504821\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504781\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504782\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299870\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504824\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504828\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504777\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504778\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504780\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11393286\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504944\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322400\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504948\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961999\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504869\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504889\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9900\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9900|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?19/7/19572?source=related_link\">",
"      Phenylephrine (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?20/52/21316?source=related_link\">",
"      Phenylephrine (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/10/17572?source=related_link\">",
"      Phenylephrine (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/7/23668?source=related_link\">",
"      Phenylephrine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?36/50/37668?source=related_link\">",
"      Phenylephrine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/13/40147?source=related_link\">",
"      Phenylephrine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?32/59/33717?source=related_link\">",
"      Phenylephrine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/23/13686?source=related_link\">",
"      Phenylephrine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/53/30547?source=related_link\">",
"      Phenylephrine (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/36/20036?source=related_link\">",
"      Phenylephrine (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/16/5379?source=related_link\">",
"      Phenylephrine (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_47_6904="White piedra";
var content_f6_47_6904=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F69898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F69898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    White piedra",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 331px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 25-year-old woman noted increasing numbers of white spots on her scalp hairs. Examination of the hair shafts showed multiple white nodules completely encircling the hair shafts. Groin, axillary and less commonly scalp hair can be involved.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Samuel Freire da Silva, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6904=[""].join("\n");
var outline_f6_47_6904=null;
var title_f6_47_6905="Psychological aspects of pregnancy termination";
var content_f6_47_6905=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Psychological aspects of pregnancy termination",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/47/6905/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6905/contributors\">",
"     Uta Landy, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6905/contributors\">",
"     Philip D Darney, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/47/6905/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6905/contributors\">",
"     Mimi Zieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/47/6905/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6905/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/47/6905/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H8719354\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States in 2008, there were 6.4 million pregnancies among 62 million women. Fifty percent of pregnancies were unintended and 19 percent of pregnancies resulted in pregnancy termination [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/1\">",
"     1",
"    </a>",
"    ]. Advances in prenatal testing for fetal abnormalities has increased the number of terminations of intended pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The psychological impact of pregnancy termination is controversial. The evidence regarding this issue is generally of low quality and study design is inconsistent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/4\">",
"     4",
"    </a>",
"    ]. In particular, many studies do not use validated mental health measures, pre-abortion mental status is often not controlled for, and the presence and type of comparison group are variable [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/5\">",
"     5",
"    </a>",
"    ]. Available systematic reviews have reached opposing conclusions and concerns have been raised regarding methodology [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. In addition, the circumstance of an unwanted pregnancy involves many other factors that are likely to be associated with emotional distress. Psychological responses to pregnancy termination often vary by social, cultural, religious, or legal context, so generalizations across populations are difficult to make [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The psychosocial aspects of pregnancy termination are reviewed here. Other issues regarding pregnancy termination are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19498?source=see_link\">",
"     \"Overview of pregnancy termination\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H392034\">",
"    <span class=\"h1\">",
"     EVIDENCE REGARDING POTENTIAL OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evidence regarding the epidemiology of mental health outcomes following pregnancy termination for unintended pregnancy is reviewed in the sections that follow. Psychological outcomes of pregnancy termination due to fetal abnormalities are discussed in a separate section. (See",
"    <a class=\"local\" href=\"#H4556071\">",
"     'Termination for fetal anomalies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Based upon existing evidence, it is known that many women struggle with decisions to end pregnancies. The conflicts and ambivalence regarding the abortion decision appear to occur mostly before the abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/10\">",
"     10",
"    </a>",
"    ]. While unintended pregnancy brings about a crisis and concomitant stress for many women, the pregnancy termination is commonly perceived as a resolution of the crisis leading to a sense of relief. Most women do not develop serious mental health disorders, such as depression [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Systematic reviews by professional societies, the American Psychological Association (APA) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/4\">",
"     4",
"    </a>",
"    ] and the United Kingdom National Collaborating Centre for Mental Health (NCCMH) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/6\">",
"     6",
"    </a>",
"    ], found no increase in the risk of mental health disorders associated with pregnancy termination.",
"   </p>",
"   <p>",
"    In contrast, a meta-analysis of 22 studies found an 81 percent increased risk of mental health problems among women who had a prior abortion, with 10 percent of this risk attributable to abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/7\">",
"     7",
"    </a>",
"    ]. However, this analysis has been the subject of considerable controversy and did not provide an assessment of the quality of studies or control for previous mental health history [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/5,6,13\">",
"     5,6,13",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16869209\">",
"    <span class=\"h2\">",
"     Anxiety",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many women experience anxiety symptoms just prior to pregnancy termination, but abortion is not associated with an increase in the long-term risk of anxiety symptoms. A literature review of 24 studies found that, in good quality studies, 40 to 45 percent of women planning an abortion had significant levels of anxiety [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/14\">",
"     14",
"    </a>",
"    ]. One study reported that the most common factor associated with anxiety was anticipation of pain [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/15\">",
"     15",
"    </a>",
"    ]. Most studies in the literature review found a decreased prevalence of anxiety in the month following pregnancy termination.",
"   </p>",
"   <p>",
"    Regarding the long-term risk of anxiety, the best designed study was a cross-sectional analysis that included 3482 women with an unintended first pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/16\">",
"     16",
"    </a>",
"    ]. There was no significant difference in the rate of post-pregnancy anxiety symptoms (lasting six or more months) in women who had an abortion compared with those who had a delivery, after controlling for pre-pregnancy anxiety symptoms and rape experience.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H392043\">",
"    <span class=\"h2\">",
"     Depression and suicide",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are conflicting data regarding the association of pregnancy termination with a long-term risk of depression and suicide. The studies that have addressed this question are mostly retrospective. In general, the highest quality studies have found no increase in the long-term risk of depression or suicide associated with induced abortion.",
"   </p>",
"   <p>",
"    Depressive symptoms are present in some women (20 percent) following the diagnosis of pregnancy and prior to termination, based upon the better quality studies in a literature review of 24 studies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following abortion, women may experience positive emotions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/12,17\">",
"     12,17",
"    </a>",
"    ]. As an example, in one study of 292 women surveyed two weeks following pregnancy termination, the majority reported feeling happy (76 percent); the most frequent negative emotion was guilt (19 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There appears to be no long-term increase in the risk of depression associated with pregnancy termination, although there are conflicting data. Two retrospective studies regarding the risk of depression following abortion used the same data source, the United States National Longitudinal Survey of Youth, but reached different conclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. A systematic review that assessed study quality found that one of the studies was of higher quality, because it used the original coding system of the survey and had less risk of selection bias [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/21\">",
"     21",
"    </a>",
"    ]. In that study (n = 1247), girls between age 14 to 21 years in 1979 were surveyed annually until 1992 [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/19\">",
"     19",
"    </a>",
"    ]. After 1980, those with an unwanted first pregnancy who had undergone termination versus delivery had no significantly different risk of having depression, based upon a standardized depression scale (both groups had a 24 percent risk). Prior to 1980, participants who terminated a pregnancy were statistically significantly less likely than those who delivered to be at high risk of depression (24 versus 35 percent). &nbsp;",
"   </p>",
"   <p>",
"    The systematic review that assessed study quality found that there were no high quality data to support an increased risk of suicide associated with pregnancy termination [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A population-based retrospective cohort study of Danish women from 1995 to 2007 found a higher baseline rate of mental health disorders in women undergoing termination compared with childbirth, but did not find that the termination was associated with an increase in these disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/22\">",
"     22",
"    </a>",
"    ]. The study analyzed data regarding the rate for first psychiatric contact (outpatient diagnosis or psychiatric admission) in women and girls with a first pregnancy. For all mental health disorders, there was no significant difference in the rate of first psychiatric contact following termination compared with before the procedure (15.2 versus 14.6 per 1000 person-years; 1.5 versus 1.0 percent). In contrast, women who underwent childbirth had statistically significantly higher rates of psychiatric contact after compared with before delivery (6.7 versus 3.9 per 1000 person-years; 0.7 versus 0.3 percent). Regarding the risk of depression, a subset analysis of affective disorders was consistent with the findings for all mental health disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8271402\">",
"    <span class=\"h2\">",
"     Psychosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A prospective cohort study (n = 13,261) found that women without a history of mental illness had a lower relative risk of psychosis after abortion than after childbirth, although rates of psychosis leading to hospitalization were similar [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/24\">",
"     24",
"    </a>",
"    ]. Few studies specifically address abortion and psychosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8271410\">",
"    <span class=\"h2\">",
"     Posttraumatic stress disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some research has suggested a relationship between posttraumatic stress disorder (PTSD) symptoms and pregnancy termination [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Other research has indicated that common risk factors account for those symptoms, suggesting that prior mental health problems and history of sexual abuse are significant factors in both PTSD and abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H392051\">",
"    <span class=\"h2\">",
"     Regret",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few studies of presence or absence of regret following pregnancy termination. One study (n = 442) indicated that most women do not experience regret after abortion, but those who do tend to have a history of depression [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H392059\">",
"    <span class=\"h2\">",
"     Stigma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many women are concerned about social stigma related to pregnancy termination [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. As an example, in a study of 442 women followed for two years after pregnancy termination, 47 percent reported that others would disapprove of them as a result of their abortion and 44 percent felt they needed to keep the abortion a secret from family",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    friends [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/32\">",
"     32",
"    </a>",
"    ]. Stigma may contribute to the internalization of negative perceptions of self, as well as negatively influence patient perception of the abortion experience [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8271477\">",
"    <span class=\"h2\">",
"     Substance abuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have found that women who had multiple abortions are more likely to have a substance abuse disorder than women who had one or no abortions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/16,34\">",
"     16,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H391431\">",
"    <span class=\"h1\">",
"     MODIFYING FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The degree of emotional distress in response to pregnancy termination may depend upon one or more of the following factors:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prior mental health status",
"     </li>",
"     <li>",
"      Social support",
"     </li>",
"     <li>",
"      Attitude toward pregnancy termination",
"     </li>",
"     <li>",
"      Maternal age",
"     </li>",
"     <li>",
"      Prior or current relationship violence &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3232076\">",
"    <span class=\"h2\">",
"     Prior mental health status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mental health status prior to pregnancy termination appears to be the most important risk factor for subsequent psychiatric symptoms or diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/6\">",
"     6",
"    </a>",
"    ]. As an example, a prospective study (n = 80) found that anxiety or depression following termination was statistically significantly more likely in women with pre-termination psychiatric problems [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3232111\">",
"    <span class=\"h2\">",
"     Social support",
"    </span>",
"    &nbsp;&mdash;&nbsp;The psychological support available to a woman before and after pregnancy termination affects the woman's perception, experience, and future feelings about abortion. Studies have found that low perceived or anticipated social support is associated with an increased rate of negative emotion following pregnancy termination [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. Relationship health, rather than marital status, appears to affect emotional response to abortion: most, but not all, studies have found that partner support is a key factor in reducing the risk of emotional distress [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/4,36,37\">",
"     4,36,37",
"    </a>",
"    ]. One study found that poor support from the woman&rsquo;s gynecologist was associated with severe emotional distress in women younger than age 25 years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/36\">",
"     36",
"    </a>",
"    ]. Emotional support may be provided by the woman&rsquo;s partner, family, friends, or clinicians or counselors [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4555454\">",
"     'Counseling for women undergoing pregnancy termination'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p>",
"    Conversely, women who report pressure from a partner or friends as the reason for having a termination appear to be more likely to have symptoms of posttraumatic stress disorder (PTSD) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/25,39\">",
"     25,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8271516\">",
"    <span class=\"h2\">",
"     Socioeconomic status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Socioeconomic status has not been demonstrated to affect psychological responses to abortion. A Swedish study (n = 444) found that while dissatisfaction with social support after abortion was common, it did not vary among socioeconomic groups [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/40\">",
"     40",
"    </a>",
"    ]. Another study found that having an abortion for &ldquo;financial reasons&rdquo; significantly correlated to a negative psychological response after the procedure, but this study did not compare women of differing socioeconomic status [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3232118\">",
"    <span class=\"h2\">",
"     Attitude toward pregnancy termination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ambivalence and a negative attitude toward abortion have been shown to be significant predictors of negative emotional responses post-abortion. As an example, in a prospective study (n = 80), a negative attitude toward abortion was associated with an increased rate of anxiety at both six months and five years after the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A woman may feel compelled to terminate an unintended pregnancy, despite a negative personal attitude toward pregnancy termination. This may make it difficult for her to accept her decision without anxiety and distress. Attitudes about abortion may be influenced by religious or legal factors [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H391700\">",
"    <span class=\"h2\">",
"     Adolescents",
"    </span>",
"    &nbsp;&mdash;&nbsp;A prospective two-year follow-up study of 360 adolescents enrolled at the time of seeking pregnancy testing found that the vast majority (95.5 percent) who chose to terminate an unplanned pregnancy reported no symptoms of psychological disturbance after the abortion and seemed to fare significantly better with regard to the completion of high school and economic well-being, particularly when they prevented a repeat pregnancy, compared to those who carried their pregnancies to term [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/42\">",
"     42",
"    </a>",
"    ]. These findings also confirm the important role of post-abortion contraception.",
"   </p>",
"   <p>",
"    A study which evaluated the emotional responses of minors [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/43\">",
"     43",
"    </a>",
"    ] pre- and post-abortion found that adolescents did not differ from other age groups in their psychological reactions after an abortion, confirming the findings of one study for adolescents and abortion. This study found that, while young women reported similar levels of comfort after their abortions, their emotional states before their abortions, and the degree to which they felt pressured to have abortions, specifically by their partners rather than parents, were predictors of subsequent negative feelings after pregnancy termination.",
"   </p>",
"   <p>",
"    Adolescents, particularly in states requiring parental involvement and judicial determinations of eligibility for abortion, are at greater risk of emotional distress [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8271547\">",
"    <span class=\"h2\">",
"     Prior or current relationship violence",
"    </span>",
"    &nbsp;&mdash;&nbsp;One study (n = 2525) found significant correlation between abortion and past experience of sexual abuse, relationship violence, or rape. When analysis controlled for this history of abuse and other socio-demographic factors, abortion was not correlated with poorer mental health [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An analysis of national comorbidity data demonstrated that, once risk factors were considered, abortion was not significantly related to suicidal ideation or depression. The analysis did find, however, that prior mental health status and gender-based violence experience were significant predictors of post-pregnancy mental health status [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/45\">",
"     45",
"    </a>",
"    ]. A separate analysis of two national surveys (n = 9683) found no significant association between depression and termination after adjustment for socio-demographic factors. The effect of violence on depression remained significant even after adjustment [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/46\">",
"     46",
"    </a>",
"    ]. Identifying, supporting, and referring women experiencing relationship violence is an effective intervention against further psychological consequences of that violence [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/47\">",
"     47",
"    </a>",
"    ]. Termination counseling provides an opportune point of intervention in the clinic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8271595\">",
"    <span class=\"h2\">",
"     History of pregnancy termination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies indicate that women who report a history of multiple abortions also report a higher rate of prior mood and anxiety disorders than women having no abortions; these women also have a higher rate of physical or sexual abuse than women having one abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/27,34\">",
"     27,34",
"    </a>",
"    ]. As noted above, relationship violence and mental health history are significant predictors of both pre- and post-abortion mental health, and screening and referral for at-risk women is an appropriate intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8271626\">",
"    <span class=\"h2\">",
"     Current family size",
"    </span>",
"    &nbsp;&mdash;&nbsp;Research indicates that women with greater numbers of children have more positive attitudes towards abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/48\">",
"     48",
"    </a>",
"    ]. Women who chose abortion because they had enough children report slightly better psychological responses two years post-procedure than women who chose abortion for other reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3232244\">",
"    <span class=\"h2\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of gestational age on psychological outcomes of elective pregnancy termination has not been determined. A systematic review of 11 comparative studies regarding termination at later gestation found studies to generally be of low quality and no studies that controlled for pre-termination mental health [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/49\">",
"     49",
"    </a>",
"    ]. Most of these studies evaluated termination for fetal anomalies. Four studies that compared women who had an induced abortion in the second trimester or later with those who had other perinatal losses found no difference in mental health outcomes.",
"   </p>",
"   <p>",
"    Medication abortion has now become a common technique, particularly for first trimester pregnancy termination. Some questions have been raised regarding whether",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/45/1753?source=see_link\">",
"     mifepristone",
"    </a>",
"    , the agent used in most medication abortions, may improve mood through its action as a glucocorticoid receptor blocker [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. In addition, the patient experiences of surgical and medication abortion differ, which could theoretically affect emotional responses: one study (n = 86) found that medication abortion patients had a higher risk of developing PTSD than surgical abortion patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/26\">",
"     26",
"    </a>",
"    ]. Two prospective studies, however, found that the technique for pregnancy termination was not associated with variation in psychological outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/17,50\">",
"     17,50",
"    </a>",
"    ]. The larger of these studies (n = 219) was a prospective cohort study in which women underwent a first trimester medication or surgical abortion. Both groups showed a statistically significant decrease in both anxiety and depression from one month before to one month after the procedure. The pre-procedure anxiety score was statistically significantly lower in the medication group than in the surgery group [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4555454\">",
"    <span class=\"h1\">",
"     COUNSELING FOR WOMEN UNDERGOING PREGNANCY TERMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Counseling before and after pregnancy termination facilitates informed decision-making, provides emotional support, and helps to identify women who require additional psychological care. Counseling can also reduce likelihood of negative emotional experiences after an abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/52\">",
"     52",
"    </a>",
"    ]. A variety of approaches to counseling is available and resources are available for clinicians [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17924696\">",
"    <span class=\"h2\">",
"     Counseling before termination",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H438164\">",
"    <span class=\"h3\">",
"     Source of counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some women who are considering pregnancy termination go directly to an abortion clinic, while others seek the advice of their primary care clinician, gynecologist, midwife, or other health care providers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H438146\">",
"    <span class=\"h4\">",
"     Referring clinician",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referring clinicians can play an important role in counseling women regarding pregnancy termination [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/10\">",
"     10",
"    </a>",
"    ]. An awareness of the potential emotional issues involved in this process is helpful in providing appropriate counseling and in identifying patients who may require additional psychological care. Some clinicians may be opposed to pregnancy termination. However, codes of medical ethics require clinicians to provide impartial information and referrals to patients. Regarding pregnancy termination, the American College of Obstetricians and Gynecologists (ACOG) advises, &ldquo;All health care providers must provide accurate and unbiased information so that patients can make informed decisions&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/55\">",
"     55",
"    </a>",
"    ]. The American College of Physicians (ACP) states, &ldquo;As in any other medical situation, the physician has a duty to refer the patient to an appropriate source for the full range of options so that the patient's legal options are not constrained [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/56\">",
"     56",
"    </a>",
"    ].&rdquo;",
"   </p>",
"   <p>",
"    A referring clinician should be able to provide contact information for abortion providers and should have a general knowledge of different options for pregnancy termination. A referral list based upon personal knowledge of colleagues and previous experiences of patients is immensely helpful to the woman and preferable to advising a patient to check a printed or online directory.",
"   </p>",
"   <p>",
"    Clinicians should be aware that it may be difficult for a patient to bring up the subject of pregnancy termination and should approach the patient in a manner that puts the patient at ease and avoids a perception of stigma. As noted above, one study found that poor support from the woman&rsquo;s gynecologist is associated with severe emotional distress in women younger than age 25 years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3232111\">",
"     'Social support'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H438180\">",
"    <span class=\"h4\">",
"     Clinician or clinic performing the termination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy termination may be provided in a physician&rsquo;s office or in a hospital or clinic. In any of these settings, counseling should be provided before and after the termination, with the following goals:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assist in decision-making regarding termination.",
"     </li>",
"     <li>",
"      Provide information regarding the procedure, including different types of procedures, if appropriate, details of the procedure (including risk of complications or post-termination health risks), and follow-up care. Written information is useful for the patient to be able to refer to later. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19498?source=see_link&amp;anchor=H24#H24\">",
"       \"Overview of pregnancy termination\", section on 'Complications'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Review payment options",
"     </li>",
"     <li>",
"      Provide emotional support and help the patient identify sources of social support. Identify patients with psychological symptoms or conditions who require additional psychological evaluation or care; abortion providers should have a list of resources for referrals as needed (eg, for adoption agencies or psychotherapists).",
"     </li>",
"     <li>",
"      Provide information about post-termination contraception (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24713?source=see_link\">",
"       \"Postpartum and postabortion contraception\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The sections that follow focus on the psychological aspects of pregnancy termination counseling. Medical and other issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19498?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of pregnancy termination\", section on 'Preoperative considerations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19498?source=see_link&amp;anchor=H36#H36\">",
"     \"Overview of pregnancy termination\", section on 'Follow up'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17924703\">",
"    <span class=\"h3\">",
"     Decision-making",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important for clinicians and counselors to acknowledge the individual situation of the patient and to offer support in decision-making. Many private and public family planning and abortion services offer decision-making counseling and employ staff specifically trained to help the woman with this process. Several studies have found that the process of decision-making is a key factor in post-abortion reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/57-59\">",
"     57-59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unintended pregnancies are not necessarily unwanted, but financial problems, age and maturity, and lack of a supportive partner or parents may contribute to the decision to terminate. For women who feel compelled by their circumstances to have an abortion, reactions may range from welcoming the opportunity to end the pregnancy safely to feelings of profound ambivalence and outright disapproval. The latter is particularly true for women who have an anti-abortion perspective or believe that abortion is akin to murder. The clinician or counselor can help in identifying the key issues and considerations to facilitate a decision which will prevent negative psychological responses in the future. For women who feel ambivalent about an abortion decision, feelings of sadness and grieving are appropriate responses and women benefit from the opportunity to express a range of feelings about the pregnancy and potential parenthood [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/57\">",
"     57",
"    </a>",
"    ]. Women with a great degree of emotional conflict may benefit from referral to a psychotherapist.",
"   </p>",
"   <p>",
"    Women should ideally make the decision of carrying a pregnancy to term or terminating it without coercion and with the support of their partners, families, and health care providers. For adolescent patients, particular attention should be paid to the possibility of pressure to terminate or continue her pregnancy by her partner or parent. Clinicians or counselors should ask women considering pregnancy termination whether they feel pressured into making a particular choice, and should provide unbiased counseling to help a woman arrive at her own decision.",
"   </p>",
"   <p>",
"    Control of decision-making may be an aspect of intimate partner violence. Some data suggest that women who experience intimate partner violence are more likely to have repeat terminations [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. This may be due to being prevented from using contraception by a partner. In one study of women undergoing medication abortion, intimate partner violence was more common in women who were white, were unmarried, had previous spontaneous or induced abortions, and incorrectly estimated their gestational age. Screening and counseling for intimate partner violence should be provided, if appropriate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/15/6393?source=see_link\">",
"     \"Intimate partner violence: Diagnosis and screening\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H438366\">",
"    <span class=\"h3\">",
"     Emotional support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies suggest that counseling support before and after the abortion can have a positive effect on mental state and perception of the pregnancy termination experience [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinicians and counselors can discuss concerns and feelings that a woman has about pregnancy termination, including issues such as relationship health or attitudes toward abortion that may impact a woman&rsquo;s emotional response. The discussion may also identify sources of emotional support outside of the clinician or counselor, such as social support, therapy, and abortion talk lines. Post-abortion support talk lines can provide ongoing emotional support subsequent to an abortion, particularly benefiting women who experience distress that does not manifest while in the clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinician or counselor can help the woman to identify potential coping mechanisms, particularly if the woman is experiencing or anticipates emotional distress. One study (n = 5109) found that most women anticipated positive emotions following pregnancy termination, but those who anticipated poor coping were women with a history of depression, who were uncertain about or felt pushed into making the decision, had spiritual concerns about abortion, and adolescents anticipated poor coping [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/63\">",
"     63",
"    </a>",
"    ]. Another study (n = 114) found that the presence of a support person in the abortion recovery space resulted in a significant decrease in pre- to postoperative anxiety levels [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17924717\">",
"    <span class=\"h3\">",
"     Identifying women at risk of adverse outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of validated inventories are available to help determine the woman's state of anxiety and depression pre- and post-abortion. The Brief Symptom Inventory (BSI), as an example, is a 10-minute test which includes symptom scales measuring Somatization, Obsessive Compulsive tendencies, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and Psychoticism [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/65\">",
"     65",
"    </a>",
"    ]. Other non-validated evaluation questions include the Harris Tools [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/10\">",
"     10",
"    </a>",
"    ], which are based on the clinical experiences of several authors with experience in abortion counseling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link&amp;anchor=H23#H23\">",
"     \"Clinical manifestations and diagnosis of depression\", section on 'Screening tools'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11782?source=see_link&amp;anchor=H5619330#H5619330\">",
"     \"Acute procedure anxiety in adults: Course, screening, assessment, and differential diagnosis\", section on 'Screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the rare circumstances when a woman might be at risk of suicide or self-harm, she should be referred to a qualified mental health professional or crisis services. In other situations where distress is expressed by the patient, referrals to further in-clinic counseling, community support organizations or abortion talk lines may be an appropriate addition to mental health referrals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17924724\">",
"    <span class=\"h2\">",
"     Counseling after termination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Counseling after pregnancy termination presents another opportunity to identify women at risk for significant emotional distress. As noted above, assessment for current symptoms or a prior history of mental health disorders are key components of this evaluation.",
"   </p>",
"   <p>",
"    The expression of feelings of sadness and grief should be acknowledged, if present, and are beneficial to the woman's ability to cope following pregnancy termination. Women who need further post-pregnancy termination emotional support should be referred to therapists or organizations that offer support services, as women rarely return to the abortion provider for postabortion support.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H439068\">",
"    <span class=\"h1\">",
"     TERMINATION FOR FETAL ANOMALIES OR MULTIPLE GESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4556071\">",
"    <span class=\"h2\">",
"     Termination for fetal anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in techniques for prenatal testing have resulted in the ability to diagnose many fetal abnormalities during pregnancy. Women and their partners who receive a diagnosis of a fetal abnormality must make a challenging decision regarding pregnancy termination or care or continuing the pregnancy. In addition, women with a multiple gestation may undergo selective termination if one fetus has an abnormality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39065?source=see_link&amp;anchor=H15#H15\">",
"     \"Multifetal pregnancy reduction and selective termination\", section on 'Selective termination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Counseling women who consider termination after confirmation of fetal anomalies demands special considerations; the pregnancy termination typically occurs at a time in the gestation when there is greater investment in the pregnancy. In addition, the pregnancy was likely to have been intended. Both factors can make the decision more painful. Guiding these women about grieving and providing a referral to a psychotherapist or support organization within the community can be particularly helpful.",
"   </p>",
"   <p>",
"    Studies have found that women who terminate a pregnancy because of a fetal abnormality are likely to experience significant emotional distress. This level of distress is similar to women who have pregnancy loss during the second trimester or later [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/49\">",
"     49",
"    </a>",
"    ]. In one study (n = 147), at four months after termination for a fetal anomaly, many women had symptoms of posttraumatic stress or depression (46 and 28 percent, respectively). The proportion of women with these symptoms was somewhat decreased at 16-month follow-up (21 and 13 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prenatal diagnosis testing is available for some conditions during first trimester, but most fetal abnormalities are diagnosed in second trimester. One study found that women who underwent pregnancy termination for a fetal anomaly in the second trimester were more likely to have posttraumatic stress symptoms than those who had a first trimester termination [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6905/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H439102\">",
"    <span class=\"h2\">",
"     Multifetal pregnancy reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with a multiple gestation may choose to terminate one or more of the fetuses to avoid complications of high order multiple gestation. The psychological outcomes of this procedure are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39065?source=see_link&amp;anchor=H13#H13\">",
"     \"Multifetal pregnancy reduction and selective termination\", section on 'Psychological outcome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17924747\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The circumstance of an unwanted pregnancy or the discovery of a fetal anomaly involves many factors that are likely to be associated with emotional distress. The responses of women to these situations vary by individual emotional resilience, as well as age, social, cultural, religious, and legal context. (See",
"      <a class=\"local\" href=\"#H8719354\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The immediate and long-term psychological impacts of pregnancy termination are controversial. Systematic reviews by professional societies, the American Psychological Association (APA) and the United Kingdom National Collaborating Centre for Mental Health (NCCMH), found no increase in the risk of mental health disorders associated with pregnancy termination. (See",
"      <a class=\"local\" href=\"#H392034\">",
"       'Evidence regarding potential outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The degree of emotional distress in response to pregnancy termination may depend upon one or more of the following factors: prior mental health status, social support, attitude toward pregnancy termination, and adolescent age. (See",
"      <a class=\"local\" href=\"#H391431\">",
"       'Modifying factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The technique for pregnancy termination (ie, surgery or medication) does not appear to impact psychological outcomes. (See",
"      <a class=\"local\" href=\"#H3232244\">",
"       'Other factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary care clinicians and",
"      <span class=\"nowrap\">",
"       obstetrician/gynecologists",
"      </span>",
"      should be properly informed about the methods of pregnancy termination, their risks and benefits, and, if not offering pregnancy termination services, should be able to make appropriate referrals. (See",
"      <a class=\"local\" href=\"#H438146\">",
"       'Referring clinician'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnancy termination counseling should include assessment of current symptoms or prior diagnoses of mental health disorders. Administration of a psychometric test may be useful. If indicated, psychological or psychiatric consultation should be recommended pre- or post-abortion. (See",
"      <a class=\"local\" href=\"#H17924717\">",
"       'Identifying women at risk of adverse outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     file://www.guttmacher.org/datacenter/profiles/US.jsp (Accessed on April 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/2\">",
"      Salvesen KA, Oyen L, Schmidt N, et al. Comparison of long-term psychological responses of women after pregnancy termination due to fetal anomalies and after perinatal loss. Ultrasound Obstet Gynecol 1997; 9:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/3\">",
"      Davies V, Gledhill J, McFadyen A, et al. Psychological outcome in women undergoing termination of pregnancy for ultrasound-detected fetal anomaly in the first and second trimesters: a pilot study. Ultrasound Obstet Gynecol 2005; 25:389.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.nccmh.org.uk/publications_SR_abortion_in_MH.html (Accessed on April 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/5\">",
"      Kendall T, Bird V, Cantwell R, Taylor C. To meta-analyse or not to meta-analyse: abortion, birth and mental health. Br J Psychiatry 2012; 200:12.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.apa.org/pi/women/programs/abortion/mental-health.pdf (Accessed on April 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/7\">",
"      Coleman PK. Abortion and mental health: quantitative synthesis and analysis of research published 1995-2009. Br J Psychiatry 2011; 199:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/8\">",
"      Thorp JM Jr, Hartmann KE, Shadigian E. Long-term physical and psychological health consequences of induced abortion: review of the evidence. Obstet Gynecol Surv 2003; 58:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/9\">",
"      Cameron S. Induced abortion and psychological sequelae. Best Pract Res Clin Obstet Gynaecol 2010; 24:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/10\">",
"      Harris AA. Supportive counseling before and after elective pregnancy termination. J Midwifery Womens Health 2004; 49:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/11\">",
"      Adler NE, David HP, Major BN, et al. Psychological responses after abortion. Science 1990; 248:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/12\">",
"      Adler NE, David HP, Major BN, et al. Psychological factors in abortion. A review. Am Psychol 1992; 47:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/13\">",
"      Steinberg JR, Trussell J, Hall KS, Guthrie K. Fatal flaws in a recent meta-analysis on abortion and mental health. Contraception 2012; 86:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/14\">",
"      Bradshaw Z, Slade P. The effects of induced abortion on emotional experiences and relationships: a critical review of the literature. Clin Psychol Rev 2003; 23:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/15\">",
"      Lauzon P, Roger-Achim D, Achim A, Boyer R. Emotional distress among couples involved in first-trimester induced abortions. Can Fam Physician 2000; 46:2033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/16\">",
"      Steinberg JR, Russo NF. Abortion and anxiety: what's the relationship? Soc Sci Med 2008; 67:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/17\">",
"      Hemmerling A, Siedentopf F, Kentenich H. Emotional impact and acceptability of medical abortion with mifepristone: a German experience. J Psychosom Obstet Gynaecol 2005; 26:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/18\">",
"      Lazarus A. Psychiatric sequelae of legalized elective first trimester abortion. J Psychosom Obstet Gynaecol 1985; 4:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/19\">",
"      Schmiege S, Russo NF. Depression and unwanted first pregnancy: longitudinal cohort study. BMJ 2005; 331:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/20\">",
"      Reardon DC, Cougle JR. Depression and unintended pregnancy in the National Longitudinal Survey of Youth: a cohort study. BMJ 2002; 324:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/21\">",
"      Charles VE, Polis CB, Sridhara SK, Blum RW. Abortion and long-term mental health outcomes: a systematic review of the evidence. Contraception 2008; 78:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/22\">",
"      Munk-Olsen T, Laursen TM, Pedersen CB, et al. Induced first-trimester abortion and risk of mental disorder. N Engl J Med 2011; 364:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/23\">",
"      Munk-Olsen T, Laursen TM, Pedersen CB, et al. First-time first-trimester induced abortion and risk of readmission to a psychiatric hospital in women with a history of treated mental disorder. Arch Gen Psychiatry 2012; 69:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/24\">",
"      Gilchrist AC, Hannaford PC, Frank P, Kay CR. Termination of pregnancy and psychiatric morbidity. Br J Psychiatry 1995; 167:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/25\">",
"      Rue VM, Coleman PK, Rue JJ, Reardon DC. Induced abortion and traumatic stress: a preliminary comparison of American and Russian women. Med Sci Monit 2004; 10:SR5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/26\">",
"      Rousset C, Brulfert N, Sejourne N, et al.. Posttraumatic stress disorder and psychological distress following medical and surgical abortion. J Reprod Infant Psychol 2011; 29:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/27\">",
"      Steinberg JR, Finer LB. Examining the association of abortion history and current mental health: A&nbsp;reanalysis of the National Comorbidity Survey using a common-risk-factors model. Soc Sci Med 2011; 72:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/28\">",
"      Robinson GE, Stotland NL, Russo NF, et al. Is there an \"abortion trauma syndrome\"? Critiquing the evidence. Harv Rev Psychiatry 2009; 17:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/29\">",
"      Major B, Cozzarelli C, Cooper ML, et al. Psychological responses of women after first-trimester abortion. Arch Gen Psychiatry 2000; 57:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/30\">",
"      Astbury-Ward E, Parry O, Carnwell R. Stigma, abortion, and disclosure--findings from a qualitative study. J Sex Med 2012; 9:3137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/31\">",
"      Harris LH. Stigma and abortion complications in the United States. Obstet Gynecol 2012; 120:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/32\">",
"      Major B, Gramzow RH. Abortion as stigma: cognitive and emotional implications of concealment. J Pers Soc Psychol 1999; 77:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/33\">",
"      Norris A, Bessett D, Steinberg JR, et al. Abortion stigma: a reconceptualization of constituents, causes, and consequences. Womens Health Issues 2011; 21:S49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/34\">",
"      Fisher WA, Singh SS, Shuper PA, et al. Characteristics of women undergoing repeat induced abortion. CMAJ 2005; 172:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/35\">",
"      Broen AN, Moum T, B&ouml;dtker AS, Ekeberg O. Predictors of anxiety and depression following pregnancy termination: a longitudinal five-year follow-up study. Acta Obstet Gynecol Scand 2006; 85:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/36\">",
"      S&ouml;derberg H, Janzon L, Sj&ouml;berg NO. Emotional distress following induced abortion: a study of its incidence and determinants among abortees in Malm&ouml;, Sweden. Eur J Obstet Gynecol Reprod Biol 1998; 79:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/37\">",
"      Rizzardo R, Novarin S, Forza G, Cosentino M. Personality and psychological distress in legal abortion, threatened miscarriage and normal pregnancy. Psychother Psychosom 1991; 56:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/38\">",
"      Kimport K, Foster K, Weitz TA. Social sources of women's emotional difficulty after abortion: lessons from women's abortion narratives. Perspect Sex Reprod Health 2011; 43:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/39\">",
"      Broen AN, Moum T, B&ouml;dtker AS, Ekeberg O. Reasons for induced abortion and their relation to women's emotional distress: a prospective, two-year follow-up study. Gen Hosp Psychiatry 2005; 27:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/40\">",
"      Hamark B, Uddenberg N, Forssman L. The influence of social class on parity and psychological reactions in women coming for induced abortion. Acta Obstet Gynecol Scand 1995; 74:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/41\">",
"      Tomal A. Parental involvement laws, religion, and abortion rates. Gend Issues 2000; 18:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/42\">",
"      Zabin LS, Hirsch MB, Emerson MR. When urban adolescents choose abortion: effects on education, psychological status and subsequent pregnancy. Fam Plann Perspect 1989; 21:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/43\">",
"      Pope LM, Adler NE, Tschann JM. Postabortion psychological adjustment: are minors at increased risk? J Adolesc Health 2001; 29:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/44\">",
"      Russo NF, Denious JE. Violence in the lives of women having abortions: Implications for practice and public policy. Prof Psychol Res Pract 2001; 32:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/45\">",
"      Steinberg JR, Becker D, Henderson JT. Does the outcome of a first pregnancy predict depression, suicidal ideation, or lower self-esteem? Data from the National Comorbidity Survey. Am J Orthopsychiatry 2011; 81:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/46\">",
"      Taft AJ, Watson LF. Depression and termination of pregnancy (induced abortion) in a national cohort of young Australian women: the confounding effect of women's experience of violence. BMC Public Health 2008; 8:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/47\">",
"      Bacchus LJ, Bewley S, Vitolas CT, et al. Evaluation of a domestic violence intervention in the maternity and sexual health services of a UK hospital. Reprod Health Matters 2010; 18:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/48\">",
"      Moseley DT, Follingstad DR, Harley H, Heckel RV. Psychological factors that predict reaction to abortion. J Clin Psychol 1981; 37:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/49\">",
"      Steinberg JR. Later abortions and mental health: psychological experiences of women having later abortions--a critical review of research. Womens Health Issues 2011; 21:S44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/50\">",
"      Sit D, Rothschild AJ, Creinin MD, et al. Psychiatric outcomes following medical and surgical abortion. Hum Reprod 2007; 22:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/51\">",
"      Young AH, Gallagher P, Watson S, et al. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 2004; 29:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/52\">",
"      Mueller P, Major B. Self-blame, self-efficacy, and adjustment to abortion. J Pers Soc Psychol 1989; 57:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/53\">",
"      Upadhyay UD, Cockrill K, Freedman LR. Informing abortion counseling: an examination of evidence-based practices used in emotional care for other stigmatized and sensitive health issues. Patient Educ Couns 2010; 81:415.",
"     </a>",
"    </li>",
"    <li>",
"     Perrucci, A. Decision assessment and counseling in abortion care, Rowman &amp; Littlefield, Lanham, Maryland 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/55\">",
"      American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 385 November 2007: the limits of conscientious refusal in reproductive medicine. Obstet Gynecol 2007; 110:1203.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/about-ethics-group/ethics-resource-center/educational-resources/federation-repository-ethics-documents-online/american-college-physicians/acp-physician-and-patient.page? (Accessed on June 04, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/57\">",
"      Kero A, H&ouml;gberg U, Lalos A. Wellbeing and mental growth-long-term effects of legal abortion. Soc Sci Med 2004; 58:2559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/58\">",
"      Turell SC, Armsworth MW, Gaa JP. Emotional response to abortion: a critical review of the literature. Women Ther 1990; 9:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/59\">",
"      Trost JE. Abortions in relation to age, coital frequency, and fecundity. Arch Sex Behav 1986; 15:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/60\">",
"      McCloskey LA, Williams CM, Lichter E, et al. Abused women disclose partner interference with health care: an unrecognized form of battering. J Gen Intern Med 2007; 22:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/61\">",
"      Roth L, Sheeder J, Teal SB. Predictors of intimate partner violence in women seeking medication abortion. Contraception 2011; 84:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/62\">",
"      Kimport K, Perrucci A, Weitz TA. Addressing the silence in the noise: how abortion support talklines meet some women's needs for non-political discussion of their experiences. Women Health 2012; 52:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/63\">",
"      Foster DG, Gould H, Kimport K. How women anticipate coping after an abortion. Contraception 2012; 86:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/64\">",
"      Veiga MB, Lam M, Gemeinhardt C, et al. Social support in the post-abortion recovery room: evidence from patients, support persons and nurses in a Vancouver clinic. Contraception 2011; 83:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/65\">",
"      Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6905/abstract/66\">",
"      Korenromp MJ, Page-Christiaens GC, van den Bout J, et al. Adjustment to termination of pregnancy for fetal anomaly: a longitudinal study in women at 4, 8, and 16 months. Am J Obstet Gynecol 2009; 201:160.e1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14193 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-C008A65255-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6905=[""].join("\n");
var outline_f6_47_6905=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17924747\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8719354\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H392034\">",
"      EVIDENCE REGARDING POTENTIAL OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16869209\">",
"      Anxiety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H392043\">",
"      Depression and suicide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8271402\">",
"      Psychosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8271410\">",
"      Posttraumatic stress disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H392051\">",
"      Regret",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H392059\">",
"      Stigma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8271477\">",
"      Substance abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H391431\">",
"      MODIFYING FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3232076\">",
"      Prior mental health status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3232111\">",
"      Social support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8271516\">",
"      Socioeconomic status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3232118\">",
"      Attitude toward pregnancy termination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H391700\">",
"      Adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8271547\">",
"      Prior or current relationship violence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8271595\">",
"      History of pregnancy termination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8271626\">",
"      Current family size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3232244\">",
"      Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4555454\">",
"      COUNSELING FOR WOMEN UNDERGOING PREGNANCY TERMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17924696\">",
"      Counseling before termination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H438164\">",
"      - Source of counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H438146\">",
"      Referring clinician",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H438180\">",
"      Clinician or clinic performing the termination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17924703\">",
"      - Decision-making",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H438366\">",
"      - Emotional support",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17924717\">",
"      - Identifying women at risk of adverse outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17924724\">",
"      Counseling after termination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H439068\">",
"      TERMINATION FOR FETAL ANOMALIES OR MULTIPLE GESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4556071\">",
"      Termination for fetal anomalies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H439102\">",
"      Multifetal pregnancy reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17924747\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11782?source=related_link\">",
"      Acute procedure anxiety in adults: Course, screening, assessment, and differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/15/6393?source=related_link\">",
"      Intimate partner violence: Diagnosis and screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39065?source=related_link\">",
"      Multifetal pregnancy reduction and selective termination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19498?source=related_link\">",
"      Overview of pregnancy termination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24713?source=related_link\">",
"      Postpartum and postabortion contraception",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_47_6906="Congenital anomalies and acquired abnormalities of the optic nerve";
var content_f6_47_6906=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Congenital anomalies and acquired abnormalities of the optic nerve",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/47/6906/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6906/contributors\">",
"     Karl C Golnik, MD, MEd",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/47/6906/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6906/contributors\">",
"     Evelyn A Paysse, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/47/6906/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/47/6906/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/47/6906/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal optic nerve head (optic disc) usually is round or oval and pink in color; typically it is flat or mildly elevated and has a central depression called the cup (",
"    <a class=\"graphic graphic_picture graphicRef53796 \" href=\"UTD.htm?4/1/4112\">",
"     picture 1",
"    </a>",
"    ). The horizontal diameter of the normal optic nerve is approximately 1.5 mm. The ratio between the cup and disc diameters is important to note because acquired optic nerve damage can cause cupping, an increase in the",
"    <span class=\"nowrap\">",
"     cup/disc",
"    </span>",
"    ratio.",
"   </p>",
"   <p>",
"    Optic nerve abnormalities can be categorized as congenital or acquired. Congenital optic nerve anomalies are distinguished by the appearance of the optic disc and surrounding retina. As a general rule, these anomalies are classified according to abnormalities of optic disc size or conformation and by the presence of abnormal tissue at the nerve head (pseudoswelling). Acquired abnormalities of the optic nerve are classified according to the reaction of the optic nerve to insult: cupping, swelling, and atrophy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CONGENITAL ANOMALIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Disc size",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optic nerve head may be absent (aplasia), small (hypoplasia), or large (megalopapilla).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Aplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optic nerve aplasia is an extremely rare, nonhereditary occurrence of unknown etiology. It is characterized by complete lack of the optic nerve, disc, retinal nerve fiber layer, ganglion cells, and retinal vasculature [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Optic nerve aplasia typically is associated with a variety of other ocular malformations, including microphthalmia, cataract, anterior chamber angle malformation, retinal dysplasia, anterior coloboma (fissure or cleft of the iris or ciliary body), iris hypoplasia, and persistent fetal vasculature (formerly called persistent hyperplastic primary vitreous). Although individuals who are affected unilaterally usually are healthy otherwise, with rare exception, bilaterally affected individuals die shortly after birth [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Hypoplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optic nerve hypoplasia is the most common congenital optic disc anomaly [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/5\">",
"     5",
"    </a>",
"    ]. Bilateral involvement is more common than is unilateral [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The hypoplastic disc is small and often pale and surrounded by a yellowish halo bordered by a ring of pigmentation (double-ring sign) (",
"    <a class=\"graphic graphic_picture graphicRef70125 \" href=\"UTD.htm?4/27/4528\">",
"     picture 2",
"    </a>",
"    ). Major retinal blood vessels may be tortuous and have anomalous branching patterns. Histopathology shows subnormal numbers of axons. The normal junction between sclera and lamina cribrosa (outer ring) and termination of an abnormal extension of pigment epithelium over the lamina cribrosa (inner ring) constitute the \"double ring\" [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/8\">",
"     8",
"    </a>",
"    ]. Visual function can vary from",
"    <span class=\"nowrap\">",
"     20/20",
"    </span>",
"    to no light perception and is nonprogressive [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/9\">",
"     9",
"    </a>",
"    ]. Thus, visual prognosis in an infant is variable.",
"   </p>",
"   <p>",
"    Optic nerve hypoplasia is associated with a variety of central nervous system (CNS) and endocrine abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/7,9-12\">",
"     7,9-12",
"    </a>",
"    ]. Magnetic resonance imaging (MRI) is the study of choice for examination of the CNS; it may show thinning of the optic nerves and chiasm, absence of the septum pellucidum, and agenesis of the corpus callosum. This constellation of findings is known as septo-optic dysplasia (de Morsier syndrome).",
"   </p>",
"   <p>",
"    Other common CNS structural abnormalities in children with septo-optic dysplasia include hemispheric migration anomalies, encephalomalacia, schizencephaly, and posterior pituitary ectopia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/13\">",
"     13",
"    </a>",
"    ]. Patients with septo-optic dysplasia may have deficiencies of anterior pituitary hormones leading to dwarfism, hypothyroidism, diabetes insipidus, hypocortisolemia, and hyperprolactinemia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/14-18\">",
"     14-18",
"    </a>",
"    ]. In some of these patients, a defect in the homeobox gene expressed in ES cells (HESX1) has been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Children with bilateral optic nerve hypoplasia and septo-optic dysplasia should undergo endocrine evaluation at the time of diagnosis and at regular intervals because the hormonal insufficiencies may progress over the course of time.",
"   </p>",
"   <p>",
"    Optic nerve hypoplasia has been associated with numerous environmental factors, including maternal insulin-dependent diabetes mellitus [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/11,21\">",
"     11,21",
"    </a>",
"    ]; fetal alcohol syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/11,22,23\">",
"     11,22,23",
"    </a>",
"    ]; and maternal ingestion of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/12/19655?source=see_link\">",
"     quinine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/24\">",
"     24",
"    </a>",
"    ], anticonvulsants [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/25,26\">",
"     25,26",
"    </a>",
"    ], and illicit drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Associated systemic and ocular disorders include aniridia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/29\">",
"     29",
"    </a>",
"    ], Delleman syndrome (oculocerebrocutaneous syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/30,31\">",
"     30,31",
"    </a>",
"    ], Duane syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/32,33\">",
"     32,33",
"    </a>",
"    ], Klippel-Trenaunay-Weber syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/34\">",
"     34",
"    </a>",
"    ], Goldenhar syndrome (hemifacial microsomia) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/35\">",
"     35",
"    </a>",
"    ], linear sebaceous nevus syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/36\">",
"     36",
"    </a>",
"    ], hemifacial atrophy, Aicardi syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/37,38\">",
"     37,38",
"    </a>",
"    ], Apert syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/39\">",
"     39",
"    </a>",
"    ], Soto syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/40\">",
"     40",
"    </a>",
"    ], chromosome 13q- [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/41\">",
"     41",
"    </a>",
"    ], trisomy 18 [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/42\">",
"     42",
"    </a>",
"    ], and nonsyndromic mitochondrial cytopathies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Megalopapilla",
"    </span>",
"    &nbsp;&mdash;&nbsp;Megalopapilla is present when the disc has a normal appearance but is greater than 2.1 mm in diameter, regardless of age [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/44\">",
"     44",
"    </a>",
"    ]. Increased cupping will be noted because the same number of axons fills a larger space. Megalopapilla usually is bilateral, and cilioretinal arteries are often present [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/45\">",
"     45",
"    </a>",
"    ]. Measurements of optic nerve function are normal. Megalopapilla probably represents a physiologic variant of normal [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/46\">",
"     46",
"    </a>",
"    ]. However, a rare association between megalopapilla, anterior encephalocele, and midline facial anomalies has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/47\">",
"     47",
"    </a>",
"    ]. Thus, no further evaluation is necessary for patients with megalopapilla unless they have abnormal optic nerve function, midline facial malformations, or proptosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Disc conformation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optic disc may be of normal size but have abnormal shape, depth, blood vessel appearance, or surrounding retina.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Tilted discs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tilted discs are characterized by elevation of the superotemporal disc, posterior displacement of the inferonasal disc, situs inversus of the retinal vessels, inferonasal conus, and thinning of the inferonasal retinal pigment epithelium (RPE) and choroid (",
"    <a class=\"graphic graphic_picture graphicRef76934 \" href=\"UTD.htm?11/34/11823\">",
"     picture 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/48\">",
"     48",
"    </a>",
"    ]. These findings are bilateral in 80 percent of patients. Visual acuity is normal. A superior pseudo-bitemporal visual field defect may be present, but it does not respect the vertical midline [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/49\">",
"     49",
"    </a>",
"    ]. The visual field abnormalities are caused by refractive scotomas produced by the regional myopia from the inferonasal retina. Subretinal neovascularization rarely is associated with a tilted disc [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/50\">",
"     50",
"    </a>",
"    ]. As a general rule, no diagnostic evaluation is necessary. Tilted discs usually do not produce any visual loss and do not progress, thus no specific follow-up is indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Morning glory disc",
"    </span>",
"    &nbsp;&mdash;&nbsp;The morning glory disc anomaly consists of an enlarged, orange-pink optic disc at the center of a funnel-shaped peripapillary excavation (",
"    <a class=\"graphic graphic_picture graphicRef55325 \" href=\"UTD.htm?39/31/40433\">",
"     picture 4",
"    </a>",
"    ). The disc is surrounded by chorioretinal pigmentation, and a white tuft of glial tissue overlies its central portion. Blood vessels emanate radially from the disc, and peripapillary arteriovenous communications can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/51\">",
"     51",
"    </a>",
"    ]. The appearance is thought to mimic that of the morning glory flower. Morning glory discs usually are unilateral, occur more commonly in females, and occur rarely in African-Americans [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. They can be associated with congenital cataracts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22761?source=see_link\">",
"     \"Cataract in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Visual acuity typically is",
"    <span class=\"nowrap\">",
"     20/200",
"    </span>",
"    to finger counting, although all levels of vision have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/27\">",
"     27",
"    </a>",
"    ]. Acquired visual loss associated with the morning glory disc anomaly can occur from serous retinal detachment [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/54,55\">",
"     54,55",
"    </a>",
"    ], retinal folds [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/52\">",
"     52",
"    </a>",
"    ], and subretinal neovascularization [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Morning glory disc anomaly may be associated with midline cranial defects, including transsphenoidal encephalocele [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/52,57,58\">",
"     52,57,58",
"    </a>",
"    ]. Patients with transsphenoidal encephalocele may have wide heads, flat noses, cleft lip",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    palate, hypertelorism, agenesis of the corpus callosum, hypopituitarism, and absence of the optic chiasm [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/27,57,59\">",
"     27,57,59",
"    </a>",
"    ]. The symptoms include rhinorrhea, mouth-breathing, and snoring because the encephalocele protrudes into the nasopharynx [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/60\">",
"     60",
"    </a>",
"    ]. The diagnosis of transsphenoidal encephalocele is made with MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35575?source=see_link&amp;anchor=H6#H6\">",
"     \"Congenital anomalies of the nose\", section on 'Nasal encephaloceles'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rare associations between the morning glory disc anomaly and capillary hemangiomas [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/62\">",
"     62",
"    </a>",
"    ], abnormal carotid circulation (including moyamoya disease) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/58,63,64\">",
"     58,63,64",
"    </a>",
"    ], and renal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/65,66\">",
"     65,66",
"    </a>",
"    ] have been described.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Optic disc coloboma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optic disc coloboma (fissure or cleft) appears as a sharply defined, white, inferiorly decentered excavation of the optic disc (",
"    <a class=\"graphic graphic_picture graphicRef54267 \" href=\"UTD.htm?1/27/1457\">",
"     picture 5",
"    </a>",
"    ). The inferior neuroretinal rim is thin or absent. The defect may extend inferiorly and involve the adjacent retina and choroid; rarely, the entire disc is affected. Optic disc colobomas occur unilaterally or bilaterally with equal frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/52\">",
"     52",
"    </a>",
"    ] and may be sporadic or inherited [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/67\">",
"     67",
"    </a>",
"    ]. Visual loss is variable and difficult to predict based upon disc appearance. Macular sparing by associated chorioretinal coloboma is the best predictor of good visual acuity [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/68\">",
"     68",
"    </a>",
"    ]. Colobomas of the iris and ciliary body often coexist. Other coexisting ocular malformations include orbital cyst [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/69\">",
"     69",
"    </a>",
"    ], iris heterochromia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/70\">",
"     70",
"    </a>",
"    ], and retinal venous malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Optic disc coloboma occurs in the renal coloboma (papillorenal) syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/66,72\">",
"     66,72",
"    </a>",
"    ], an autosomal dominant trait caused by a mutation in the PAX2 gene on chromosome 10q [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/73-75\">",
"     73-75",
"    </a>",
"    ]. The PAX2 gene is expressed in primitive cells of the kidney, ureter, eye, ear, and CNS [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/76\">",
"     76",
"    </a>",
"    ]. The renal manifestations include vesicoureteral reflux, renal hypoplasia, renal failure, and chronic nephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/76\">",
"     76",
"    </a>",
"    ]. Because the renal disease potentially is life-threatening, individuals with optic disc coloboma should have a renal ultrasound to evaluate the kidney morphology. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10935?source=see_link\">",
"     \"Renal hypoplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Optic disc coloboma also has been associated with the CHARGE syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/77\">",
"     77",
"    </a>",
"    ], Walker-Warburg syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/78\">",
"     78",
"    </a>",
"    ], focal dermal hypoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/79\">",
"     79",
"    </a>",
"    ], Aicardi syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/38\">",
"     38",
"    </a>",
"    ], Goldenhar syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/80\">",
"     80",
"    </a>",
"    ], linear sebaceous nevus syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/81\">",
"     81",
"    </a>",
"    ], and Noonan syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/82\">",
"     82",
"    </a>",
"    ]. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Optic pit",
"    </span>",
"    &nbsp;&mdash;&nbsp;An optic pit is an oval or round depression in the optic disc that typically occurs temporally, although any portion of the disc may be affected (",
"    <a class=\"graphic graphic_picture graphicRef80394 \" href=\"UTD.htm?36/29/37343\">",
"     picture 6",
"    </a>",
"    ). Pits may appear gray, white, or yellowish, and cilioretinal arteries emerge from the pit in at least 50 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/83\">",
"     83",
"    </a>",
"    ]. Histologically, a pit consists of dysplastic retina that has herniated posteriorly through a defect in the lamina cribrosa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/84\">",
"     84",
"    </a>",
"    ]. The pits usually are unilateral (85 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/85\">",
"     85",
"    </a>",
"    ]. The most common visual field defects are enlargement of the blind spot with connected paracentral arcuate scotoma [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/86\">",
"     86",
"    </a>",
"    ]. Visual acuity usually is not affected by the pit, but associated serous macular detachments are common (25 to 75 percent) occurrences and typically produce central vision loss by the third and fourth decades [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/86\">",
"     86",
"    </a>",
"    ]. Macular abnormalities are more likely if the pit is large and temporally located [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/86\">",
"     86",
"    </a>",
"    ]. Ophthalmologic follow-up should be yearly or sooner if the patient notes any visual loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Peripapillary staphyloma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripapillary staphyloma is an anomaly characterized more by deep fundus excavation around the disc than by actual disc abnormality (",
"    <a class=\"graphic graphic_picture graphicRef68808 \" href=\"UTD.htm?15/0/15360\">",
"     picture 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/52\">",
"     52",
"    </a>",
"    ]. Mild temporal pallor of the disc may be present, but the blood vessels are normal. Atrophic changes in the RPE and choroid occur in the walls of the staphyloma. Occasionally, contractile movement of the walls of the staphyloma changes its shape from funnel- to tube-like [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/87\">",
"     87",
"    </a>",
"    ]. With rare exception, visual acuity is markedly reduced and cecocentral scotoma is present; cecocentral scotomas are visual field defects that include central fixation and the physiologic blind spot. Peripapillary staphyloma typically is an isolated bilateral ocular anomaly associated with axial high myopia, although it may be associated with facial capillary hemangioma [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. Children with peripapillary staphyloma should be seen by their ophthalmologist annually.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pseudoswelling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following congenital anomalies of the optic nerve may be confused with acquired optic disc swelling. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Acquired abnormalities'",
"    </a>",
"    below.) In these conditions, abnormal tissue at the nerve head appears to cause swelling (eg, pseudoswelling).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Hyperopia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperopia, or farsightedness, typically occurs in small eyes that have a small scleral opening through which optic nerve axons traverse. Such optic nerves appear small and elevated and can be mistaken for true optic disc swelling (",
"    <a class=\"graphic graphic_picture graphicRef61890 \" href=\"UTD.htm?22/54/23392\">",
"     picture 8",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Swelling'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Myelinated fibers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myelinated nerve fibers appear as striated white patches with feathery borders (",
"    <a class=\"graphic graphic_picture graphicRef75087 \" href=\"UTD.htm?9/55/10096\">",
"     picture 9",
"    </a>",
"    ). These pathognomonic borders are caused by differential myelination of individual axons. True optic disc swelling does not have this feathery appearance. Myelinated nerve fibers are ophthalmoscopically evident in 0.3 to 0.6 percent of the population and are seen in 1 percent at postmortem examination [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/90-92\">",
"     90-92",
"    </a>",
"    ]. Occurrence is bilateral in 17 to 20 percent, and they are continuous with the disc in 81 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/27\">",
"     27",
"    </a>",
"    ]. Visual acuity usually is normal, although enlarged blind spots and scotomas can occur if the myelinated area is of sufficient density. High myopia and amblyopia can occur when the myelination is severe [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/93\">",
"     93",
"    </a>",
"    ]. Myelination of the nerve fiber layer may progress after birth [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/94\">",
"     94",
"    </a>",
"    ], rarely may be acquired [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/95\">",
"     95",
"    </a>",
"    ], and will disappear when affected nerve fibers are damaged. Myelinated nerve fibers may be inherited in an autosomal dominant fashion and are a component of the Gorlin syndrome (also called the basal cell nevus syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/96\">",
"     96",
"    </a>",
"    ]. No particular ophthalmologic follow-up is necessary. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/5/44121?source=see_link\">",
"     \"Nevoid basal cell carcinoma syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Optic disc drusen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optic disc drusen are multilobulated, globular concretions composed of mucoprotein matrix with acid mucopolysaccharides and ribonucleic acids that progressively calcify [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/97\">",
"     97",
"    </a>",
"    ]. Ophthalmoscopically, disc drusen appear as multiple round to irregular, whitish-yellow dots or granules within the nerve substance, on the surface of the disc, and occasionally in the peripapillary retina (",
"    <a class=\"graphic graphic_picture graphicRef55680 \" href=\"UTD.htm?42/1/43039\">",
"     picture 10",
"    </a>",
"    ). Drusen usually are not directly visible at an early age and are said to be \"buried.\" The disc then appears elevated, and although its borders may be blurred, there should be no obscuration of disc vessels. Anomalous vascular patterns often are present on the disc surface. These \"buried\" drusen become visible as calcification progresses and nerve fibers atrophy.",
"   </p>",
"   <p>",
"    The prevalence of clinically evident disc drusen is 0.34 percent, but it increases to 3.4 percent in individuals whose family members are affected [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/97\">",
"     97",
"    </a>",
"    ]. They are more often bilateral and without gender predilection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/98\">",
"     98",
"    </a>",
"    ]. African-Americans are much less often affected than are Caucasians. Disc drusen occur at a higher prevalence in patients with retinitis pigmentosa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/99,100\">",
"     99,100",
"    </a>",
"    ], Usher syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/101\">",
"     101",
"    </a>",
"    ], Alagille syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/102\">",
"     102",
"    </a>",
"    ], and angioid streaks [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Peripheral visual field defects are the most common consequence of drusen, occurring in approximately three-quarters of patients. Visual field defects usually are slowly progressive and asymptomatic, although abrupt and episodic changes can occur. Central visual loss due to disc drusen is sufficiently rare that other causes (eg, tumor and inflammation) must be ruled out [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Superficial disc drusen have a characteristic appearance and usually do not create a diagnostic dilemma. However, \"buried\" drusen often are mistaken for true optic nerve head swelling; a variety of tests can establish their presence [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/105\">",
"     105",
"    </a>",
"    ]. Ultrasonography reveals elevation of the nerve head, and when the gain is decreased, noncalcified ocular tissue loses brightness, whereas the calcified drusen remain bright [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/106\">",
"     106",
"    </a>",
"    ]. Computed tomography (CT) shows calcification at the nerve head. Superficial drusen also can be identified with red-free photography,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"     fluorescein",
"    </a>",
"    angiography, and photographs, using the filters for fluorescein angiography (autofluorescence) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/107\">",
"     107",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Bergmeister papilla",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bergmeister papilla is white, fibrous tissue that represents persistence of the normal hyaloid vascular system. This tissue may overlay the disc or peripapillary retina in varying amounts (",
"    <a class=\"graphic graphic_picture graphicRef59155 \" href=\"UTD.htm?34/61/35807\">",
"     picture 11",
"    </a>",
"    ). Visual function should be normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ACQUIRED ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normally developed optic disc responds to injury in three ways: increased cupping, swelling, and atrophy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Cupping",
"    </span>",
"    &nbsp;&mdash;&nbsp;The central depression in the optic nerve head is called the cup. Its size varies according to the size of the scleral opening through which the optic nerve axons traverse. The cup is characterized by the ratio between the cup diameter and the disc diameter. Thus, a cup that has a diameter 50 percent of the disc diameter would be 0.5 (",
"    <a class=\"graphic graphic_picture graphicRef71031 \" href=\"UTD.htm?7/28/7616\">",
"     picture 12",
"    </a>",
"    ). Normal cupping can vary between 0.0 and 0.6, with rare instances of 0.8 being normal.",
"   </p>",
"   <p>",
"    Cupping of the optic disc increases in glaucoma as elevated intraocular pressure damages axons. Axons at the superior and inferior poles of the disc are preferentially affected. Thus, the cup tends to increase vertically in glaucomatous eyes (",
"    <a class=\"graphic graphic_picture graphicRef71467 \" href=\"UTD.htm?20/19/20799\">",
"     picture 13",
"    </a>",
"    ). Asymmetry of cupping in fellow eyes may be a sign of abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Congenital glaucoma often causes photophobia and tearing. The corneal diameter and the overall size of the eye (buphthalmos) increase as a result of increased intraocular pressure in the developing eye. Normal corneal diameter is 10 to 11 mm. Patients suspected of having congenital glaucoma should be referred immediately for ophthalmologic evaluation because congenital glaucoma is a sight-threatening disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/57/5016?source=see_link\">",
"     \"Primary infantile glaucoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Processes other than glaucoma occasionally can cause increased cupping. Compressive etiologies are reported most often [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/108,109\">",
"     108,109",
"    </a>",
"    ], but ischemia, inflammation, and periventricular leukomalacia also have been implicated [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/13,110-112\">",
"     13,110-112",
"    </a>",
"    ]. Patients with normal intraocular pressure and increased cupping should be evaluated for compressive lesions. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Compression'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Swelling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optic disc swelling is characterized by elevation of the disc, blurred or indistinct disc margins, and hemorrhage",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    exudates on the disc surface (",
"    <a class=\"graphic graphic_picture graphicRef80637 \" href=\"UTD.htm?3/6/3169\">",
"     picture 14",
"    </a>",
"    ). Concentric folds (Paton lines) may be present around the disc because the retina is being pushed aside into ridges by the swollen axons.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Papilledema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Papilledema is a subset of optic disc swelling caused by increased intracranial pressure (ICP). Thus, the term \"papilledema\" should not be applied indiscriminately to any swollen optic disc but should be reserved for cases caused by increased ICP. Papilledema occurs when alteration of axonal transport causes swelling of individual axons. The disc swelling is usually, but not always, bilateral, and vision may be normal. Very brief episodes (2 to 10 seconds) of blurry vision may occur, often with a change in posture. Patients typically have symptoms of increased ICP (eg, headache, tinnitus). Neuroimaging (MRI or CT) urgently is required to rule out space-occupying lesions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hydrocephalus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17417?source=see_link\">",
"     \"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30552?source=see_link\">",
"     \"Overview and differential diagnosis of papilledema\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/54/5994?source=see_link\">",
"     \"Hydrocephalus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammation of the optic nerve is known as optic neuritis. \"Optic neuritis\" is a nonspecific term for optic neuropathy caused by any inflammatory condition, including multiple sclerosis, sarcoidosis, contiguous sinus disease, or infection. It may also be idiopathic (\"post-viral\"). Optic disc swelling usually is mild (or may be absent altogether). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9464?source=see_link\">",
"     \"Optic neuritis: Pathophysiology, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Optic neuritis usually is unilateral and is accompanied by signs of optic neuropathy such as decreased visual acuity, a relative afferent pupillary defect (Marcus Gunn pupil), and visual field defects. A patient with optic neuritis often complains of pain with eye movement. An MRI should be performed to determine etiology. As an example, plaques suggestive of multiple sclerosis typically are found in the periventricular region, corpus callosum, centrum semiovale, and, to a lesser extent, deep white matter structures and basal ganglia. Optic neuritis usually is treated with intravenous corticosteroids and should be managed in consultation with a neurologist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29944?source=see_link\">",
"     \"Optic neuritis: Prognosis and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neuroretinitis is said to be present if a macular star of exudate occurs in an eye with optic disc swelling (",
"    <a class=\"graphic graphic_picture graphicRef71149 \" href=\"UTD.htm?4/59/5040\">",
"     picture 15",
"    </a>",
"    ). It may be idiopathic or caused by cat-scratch disease (Bartonella henselae). MRI is not necessary because no association exists between neuroretinitis and multiple sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/113\">",
"     113",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemia of the anterior optic nerve results in optic disc swelling. Although it occurs commonly in older individuals with atherosclerotic risk factors, it is extremely rare in young individuals. Severe blood loss or hypotension usually is the cause in younger individuals and, in these cases, disc swelling may be unilateral or bilateral. The disc swelling may be diffuse or sectoral (",
"    <a class=\"graphic graphic_picture graphicRef70186 \" href=\"UTD.htm?7/34/7712\">",
"     picture 16",
"    </a>",
"    ). Signs of optic nerve dysfunction (eg, decreased visual acuity, a relative afferent pupillary defect (Marcus Gunn pupil), and visual field defects) usually are present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Compression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compression of the optic nerve within the orbit may result in optic disc swelling. Proptosis usually is present, and abnormalities of eye movements may occur. Orbital MRI or CT scan is necessary to determine the source of compression. Causes of optic nerve compression include intracranial or intraorbital tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/114,115\">",
"     114,115",
"    </a>",
"    ], aneurysmal bone cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/116,117\">",
"     116,117",
"    </a>",
"    ], orbital hemorrhage or vascular anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/118-122\">",
"     118-122",
"    </a>",
"    ], orbital emphysema [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/123\">",
"     123",
"    </a>",
"    ], fibrous dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/124\">",
"     124",
"    </a>",
"    ], Graves' ophthalmopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/125\">",
"     125",
"    </a>",
"    ], or osteopetrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/126\">",
"     126",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18506?source=see_link&amp;anchor=H20#H20\">",
"     \"Bone and joint complications in sickle cell disease\", section on 'Orbital bone infarction and orbital compression syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3432?source=see_link\">",
"     \"Pathogenesis and clinical features of Graves' ophthalmopathy (orbitopathy)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Infiltration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infiltration of the optic disc by leukemia, lymphoma, metastases, or sarcoid can produce the appearance of massive disc swelling (",
"    <a class=\"graphic graphic_picture graphicRef67467 \" href=\"UTD.htm?8/1/8210\">",
"     picture 17",
"    </a>",
"    ). Severe visual loss typically is present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Atrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optic nerve damage from any cause except glaucoma (see",
"    <a class=\"local\" href=\"#H19\">",
"     'Cupping'",
"    </a>",
"    above) results in a change in the normal pink disc color to a pale or whitish appearance. This change is permanent and indicates irreversible optic nerve damage. The color change usually occurs within two to three months of the nerve damage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Diffuse atrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse optic atrophy is a nonspecific sign of optic nerve damage (",
"    <a class=\"graphic graphic_picture graphicRef76278 \" href=\"UTD.htm?25/62/26592\">",
"     picture 18",
"    </a>",
"    ). It does not help identify the etiology of the damage. Any of the acquired conditions discussed above (except glaucoma) can result in diffuse optic atrophy. Unexplained optic atrophy requires neuroimaging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Segmental atrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Segmental optic atrophy may be helpful in identifying the etiology of the optic nerve damage. Superior or inferior hemi-atrophy typically occurs after ischemic insult (",
"    <a class=\"graphic graphic_picture graphicRef57396 \" href=\"UTD.htm?0/20/320\">",
"     picture 19",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/2\">",
"     2",
"    </a>",
"    ]. Wedge-shaped temporal optic atrophy is seen in dominant optic atrophy, the most common type of hereditary optic neuropathy (",
"    <a class=\"graphic graphic_picture graphicRef55519 \" href=\"UTD.htm?14/13/14544\">",
"     picture 20",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Dominant optic atrophy is characterized by insidious onset of visual impairment in childhood, temporal disc pallor, color vision deficits, and centrocecal scotoma of variable density [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/127,128\">",
"     127,128",
"    </a>",
"    ]. It is caused by a mutation in the OPA1 gene on chromosome 3q28-q29. A possible association with Ewing sarcoma has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?6/47/6906/abstract/129\">",
"     129",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H721520758\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The normal optic nerve head (optic disc) usually is round or oval and pink in color; typically it is flat or mildly elevated and has a central depression called the cup (",
"      <a class=\"graphic graphic_picture graphicRef53796 \" href=\"UTD.htm?4/1/4112\">",
"       picture 1",
"      </a>",
"      ). The horizontal diameter of the normal optic nerve is approximately 1.5 mm. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Congenital anomalies of the optic nerve are classified according to size, conformation, and the presence of abnormal tissue at the nerve head. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Congenital anomalies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Anomalies of size include aplasia, hypoplasia (",
"      <a class=\"graphic graphic_picture graphicRef70125 \" href=\"UTD.htm?4/27/4528\">",
"       picture 2",
"      </a>",
"      ), and megalopapilla. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Disc size'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anomalies of conformation include tilted discs (",
"      <a class=\"graphic graphic_picture graphicRef76934 \" href=\"UTD.htm?11/34/11823\">",
"       picture 3",
"      </a>",
"      ), morning glory disc (",
"      <a class=\"graphic graphic_picture graphicRef55325 \" href=\"UTD.htm?39/31/40433\">",
"       picture 4",
"      </a>",
"      ), optic disc coloboma (",
"      <a class=\"graphic graphic_picture graphicRef54267 \" href=\"UTD.htm?1/27/1457\">",
"       picture 5",
"      </a>",
"      ), optic pit (",
"      <a class=\"graphic graphic_picture graphicRef80394 \" href=\"UTD.htm?36/29/37343\">",
"       picture 6",
"      </a>",
"      ), and peripapillary staphyloma (",
"      <a class=\"graphic graphic_picture graphicRef68808 \" href=\"UTD.htm?15/0/15360\">",
"       picture 7",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Disc conformation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anomalies with abnormal tissue at the nerve head include hyperopia (",
"      <a class=\"graphic graphic_picture graphicRef61890 \" href=\"UTD.htm?22/54/23392\">",
"       picture 8",
"      </a>",
"      ), myelinated fibers (",
"      <a class=\"graphic graphic_picture graphicRef75087 \" href=\"UTD.htm?9/55/10096\">",
"       picture 9",
"      </a>",
"      ), optic disc drusen (",
"      <a class=\"graphic graphic_picture graphicRef55680 \" href=\"UTD.htm?42/1/43039\">",
"       picture 10",
"      </a>",
"      ), and Bergmeister papilla (",
"      <a class=\"graphic graphic_picture graphicRef59155 \" href=\"UTD.htm?34/61/35807\">",
"       picture 11",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Pseudoswelling'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acquired abnormalities of the optic nerve are classified according to the reaction of the optic nerve to insult: cupping (",
"      <a class=\"graphic graphic_picture graphicRef71031 \" href=\"UTD.htm?7/28/7616\">",
"       picture 12",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef71467 \" href=\"UTD.htm?20/19/20799\">",
"       picture 13",
"      </a>",
"      ); swelling due to increased intracranial pressure (papilledema) (",
"      <a class=\"graphic graphic_picture graphicRef80637 \" href=\"UTD.htm?3/6/3169\">",
"       picture 14",
"      </a>",
"      ), inflammation (",
"      <a class=\"graphic graphic_picture graphicRef71149 \" href=\"UTD.htm?4/59/5040\">",
"       picture 15",
"      </a>",
"      ), ischemia (",
"      <a class=\"graphic graphic_picture graphicRef70186 \" href=\"UTD.htm?7/34/7712\">",
"       picture 16",
"      </a>",
"      ), compression, or infiltration (",
"      <a class=\"graphic graphic_picture graphicRef67467 \" href=\"UTD.htm?8/1/8210\">",
"       picture 17",
"      </a>",
"      ); and atrophy, which may be diffuse (",
"      <a class=\"graphic graphic_picture graphicRef76278 \" href=\"UTD.htm?25/62/26592\">",
"       picture 18",
"      </a>",
"      ) or segmental (",
"      <a class=\"graphic graphic_picture graphicRef57396 \" href=\"UTD.htm?0/20/320\">",
"       picture 19",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef55519 \" href=\"UTD.htm?14/13/14544\">",
"       picture 20",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Acquired abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/1\">",
"      Margo CE, Hamed LM, Fang E, Dawson WW. Optic nerve aplasia. Arch Ophthalmol 1992; 110:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/2\">",
"      Blanco R, Salvador F, Galan A, Gil-Gibernau JJ. Aplasia of the optic nerve: report of three cases. J Pediatr Ophthalmol Strabismus 1992; 29:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/3\">",
"      Storm RL, PeBenito R. Bilateral optic nerve aplasia associated with hydranencephaly. Ann Ophthalmol 1984; 16:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/4\">",
"      Weiter JJ, McLean IW, Zimmerman LE. Aplasia of the optic nerve and disk. Am J Ophthalmol 1977; 83:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/5\">",
"      Brodsky MC. Congenital optic disk anomalies. Surv Ophthalmol 1994; 39:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/6\">",
"      Zeki SM, Dutton GN. Optic nerve hypoplasia in children. Br J Ophthalmol 1990; 74:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/7\">",
"      Hellstr&ouml;m A, Wiklund LM, Svensson E. The clinical and morphologic spectrum of optic nerve hypoplasia. J AAPOS 1999; 3:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/8\">",
"      Mosier MA, Lieberman MF, Green WR, Knox DL. Hypoplasia of the optic nerve. Arch Ophthalmol 1978; 96:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/9\">",
"      Siatkowski RM, Sanchez JC, Andrade R, Alvarez A. The clinical, neuroradiographic, and endocrinologic profile of patients with bilateral optic nerve hypoplasia. Ophthalmology 1997; 104:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/10\">",
"      Ahmad T, Garcia-Filion P, Borchert M, et al. Endocrinological and auxological abnormalities in young children with optic nerve hypoplasia: a prospective study. J Pediatr 2006; 148:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/11\">",
"      Garcia ML, Ty EB, Taban M, et al. Systemic and ocular findings in 100 patients with optic nerve hypoplasia. J Child Neurol 2006; 21:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/12\">",
"      Garcia-Filion P, Epport K, Nelson M, et al. Neuroradiographic, endocrinologic, and ophthalmic correlates of adverse developmental outcomes in children with optic nerve hypoplasia: a prospective study. Pediatrics 2008; 121:e653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/13\">",
"      Brodsky MC, Glasier CM. Optic nerve hypoplasia. Clinical significance of associated central nervous system abnormalities on magnetic resonance imaging. Arch Ophthalmol 1993; 111:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/14\">",
"      Izenberg N, Rosenblum M, Parks JS. The endocrine spectrum of septo-optic dysplasia. Clin Pediatr (Phila) 1984; 23:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/15\">",
"      Willnow S, Kiess W, Butenandt O, et al. Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)--evaluation and follow up of 18 patients. Eur J Pediatr 1996; 155:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/16\">",
"      Sheridan SJ, Robb RM. Optic nerve hypoplasia with diabetes insipidus. J Pediatr Ophthalmol Strabismus 1978; 15:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/17\">",
"      Hoyt WF, Kaplan SL, Grumbach MM, Glaser JS. Septo-optic dysplasia and pituitary dwarfism. Lancet 1970; 1:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/18\">",
"      Traggiai C, Stanhope R. Endocrinopathies associated with midline cerebral and cranial malformations. J Pediatr 2002; 140:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/19\">",
"      Cohen RN, Cohen LE, Botero D, et al. Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab 2003; 88:4832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/20\">",
"      Dattani MT, Robinson IC. HESX1 and Septo-Optic Dysplasia. Rev Endocr Metab Disord 2002; 3:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/21\">",
"      Donat JF. Septo-optic dysplasia in an infant of a diabetic mother. Arch Neurol 1981; 38:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/22\">",
"      Str&ouml;mland K, Pinazo-Dur&aacute;n MD. Ophthalmic involvement in the fetal alcohol syndrome: clinical and animal model studies. Alcohol Alcohol 2002; 37:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/23\">",
"      Str&ouml;mland K, Hellstr&ouml;m A. Fetal alcohol syndrome--an ophthalmological and socioeducational prospective study. Pediatrics 1996; 97:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/24\">",
"      McKinna AJ. Quinine induced hypoplasia of the optic nerve. Can J Ophthalmol 1966; 1:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/25\">",
"      McMahon CL, Braddock SR. Septo-optic dysplasia as a manifestation of valproic acid embryopathy. Teratology 2001; 64:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/26\">",
"      Hoyt CS, Billson FA. Maternal anticonvulsants and optic nerve hypoplasia. Br J Ophthalmol 1978; 62:3.",
"     </a>",
"    </li>",
"    <li>",
"     Brodsky MC. Congenital anomalies of the optic disc. In: Walsh &amp; Hoyt's Clinical Neuro-Ophthalmology, 5th ed, Miller NR, Newman NJ (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 1998. p.755.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/28\">",
"      Dominguez R, Aguirre Vila-Coro A, Slopis JM, Bohan TP. Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child 1991; 145:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/29\">",
"      Layman PR, Anderson DR, Flynn JT. Frequent occurrence of hypoplastic optic disks in patients with aniridia. Am J Ophthalmol 1974; 77:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/30\">",
"      Delleman JW, Oorthuys JW. Orbital cyst in addition to congenital cerebral and focal dermal malformations: a new entity? Clin Genet 1981; 19:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/31\">",
"      Delleman JW, Oorthuys JW, Bleeker-Wagemakers EM, et al. Orbital cyst in addition to congenital cerebral and focal dermal malformations: a new entity. Clin Genet 1984; 25:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/32\">",
"      Aguirre-Aquino BI, Rogers DG, Traboulsi EI. A patient with de Morsier and Duane syndromes. J AAPOS 2000; 4:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/33\">",
"      Denslow GT, Sims M. Duane's retraction syndrome associated with optic nerve hypoplasia. J Pediatr Ophthalmol Strabismus 1980; 17:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/34\">",
"      O'Connor PS, Smith JL. Optic nerve variant in the Klippel-Trenaunay-Weber syndrome. Ann Ophthalmol 1978; 10:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/35\">",
"      Margolis S, Aleksic S, Charles N, et al. Retinal and optic nerve findings in Goldenhar-Gorlin syndrome. Ophthalmology 1984; 91:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/36\">",
"      Brodsky MC, Kincannon JM, Nelson-Adesokan P, Brown HH. Oculocerebral dysgenesis in the linear nevus sebaceous syndrome. Ophthalmology 1997; 104:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/37\">",
"      Font RL, Marines HM, Cartwright J Jr, Bauserman SC. Aicardi syndrome. A clinicopathologic case report including electron microscopic observations. Ophthalmology 1991; 98:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/38\">",
"      Carney SH, Brodsky MC, Good WV, et al. Aicardi syndrome: more than meets the eye. Surv Ophthalmol 1993; 37:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/39\">",
"      Teng RJ, Wang PJ, Wang TR, Shen YZ. Apert syndrome associated with septo-optic dysplasia. Pediatr Neurol 1989; 5:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/40\">",
"      B&uuml;y&uuml;kgebiz A, Er&ccedil;al D, B&ouml;ber E. Sotos syndrome with septo-optic dysplasia. J Pediatr Endocrinol Metab 1996; 9:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/41\">",
"      Weichselbaum RR, Zakov ZN, Albert DM, et al. New findings in the chromosome 13 long-arm deletion syndrome and retinoblastoma. Ophthalmology 1979; 86:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/42\">",
"      Pe'er J, Braun JT. Ocular pathology in trisomy 18 (Edwards' syndrome). Ophthalmologica 1986; 192:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/43\">",
"      Taban M, Cohen BH, David Rothner A, Traboulsi EI. Association of optic nerve hypoplasia with mitochondrial cytopathies. J Child Neurol 2006; 21:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/44\">",
"      FRANCESCHETTI A, BOCK RH. Megalopapilla; a new congenital anomaly. Am J Ophthalmol 1950; 33:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/45\">",
"      Jonas JB, Z&auml;ch FM, Gusek GC, Naumann GO. Pseudoglaucomatous physiologic large cups. Am J Ophthalmol 1989; 107:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/46\">",
"      Maisel JM, Pearlstein CS, Adams WH, Heotis PM. Large optic disks in the Marshallese population. Am J Ophthalmol 1989; 107:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/47\">",
"      Goldhammer Y, Smith JL. Optic nerve anomalies in basal encephalocele. Arch Ophthalmol 1975; 93:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/48\">",
"      Young SE, Walsh FB, Knox DL. The tilted disk syndrome. Am J Ophthalmol 1976; 82:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/49\">",
"      Brazitikos PD, Safran AB, Simona F, Zulauf M. Threshold perimetry in tilted disc syndrome. Arch Ophthalmol 1990; 108:1698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/50\">",
"      Stur M. Congenital tilted disk syndrome associated with parafoveal subretinal neovascularization. Am J Ophthalmol 1988; 105:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/51\">",
"      Brodsky MC, Wilson RS. Retinal arteriovenous communications in the morning glory disc anomaly. Arch Ophthalmol 1995; 113:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/52\">",
"      Pollock S. The morning glory disc anomaly: contractile movement, classification, and embryogenesis. Doc Ophthalmol 1987; 65:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/53\">",
"      De Laey JJ, Ryckaert S, Leys A. The 'morning glory' syndrome. Ophthalmic Paediatr Genet 1985; 5:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/54\">",
"      Haik BG, Greenstein SH, Smith ME, et al. Retinal detachment in the morning glory anomaly. Ophthalmology 1984; 91:1638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/55\">",
"      Akiyama K, Azuma N, Hida T, Uemura Y. Retinal detachment in Morning Glory syndrome. Ophthalmic Surg 1984; 15:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/56\">",
"      Sobol WM, Bratton AR, Rivers MB, Weingeist TA. Morning glory disk syndrome associated with subretinal neovascular membrane formation. Am J Ophthalmol 1990; 110:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/57\">",
"      Leitch RJ, Winter RM. Midline craniofacial defects and morning glory disc anomaly. A distinct clinical entity. Acta Ophthalmol Scand Suppl 1996; :16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/58\">",
"      Quah BL, Hamilton J, Blaser S, et al. Morning glory disc anomaly, midline cranial defects and abnormal carotid circulation: an association worth looking for. Pediatr Radiol 2005; 35:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/59\">",
"      Eustis HS, Sanders MR, Zimmerman T. Morning glory syndrome in children. Association with endocrine and central nervous system anomalies. Arch Ophthalmol 1994; 112:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/60\">",
"      Yokota A, Matsukado Y, Fuwa I, et al. Anterior basal encephalocele of the neonatal and infantile period. Neurosurgery 1986; 19:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/61\">",
"      Auber AE, O'Hara M. Morning Glory syndrome. MR imaging. Clin Imaging 1999; 23:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/62\">",
"      Holmstr&ouml;m G, Taylor D. Capillary haemangiomas in association with morning glory disc anomaly. Acta Ophthalmol Scand 1998; 76:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/63\">",
"      Komiyama M, Yasui T, Sakamoto H, et al. Basal meningoencephalocele, anomaly of optic disc and panhypopituitarism in association with moyamoya disease. Pediatr Neurosurg 2000; 33:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/64\">",
"      Krishnan C, Roy A, Traboulsi E. Morning glory disk anomaly, choroidal coloboma, and congenital constrictive malformations of the internal carotid arteries (moyamoya disease). Ophthalmic Genet 2000; 21:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/65\">",
"      Rieger G. [On the clinical picture of Handmann's anomaly of the optic nerve Morning glory syndrome? (author's transl)]. Klin Monbl Augenheilkd 1977; 170:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/66\">",
"      Dureau P, Attie-Bitach T, Salomon R, et al. Renal coloboma syndrome. Ophthalmology 2001; 108:1912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/67\">",
"      Savell J, Cook JR. Optic nerve colobomas of autosomal-dominant heredity. Arch Ophthalmol 1976; 94:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/68\">",
"      Olsen TW, Summers CG, Knobloch WH. Predicting visual acuity in children with colobomas involving the optic nerve. J Pediatr Ophthalmol Strabismus 1996; 33:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/69\">",
"      Villalonga Gorn&eacute;s PA, Galan Terraza A, Gil-Gibernau JJ. Ophthalmoscopic evolution of papillary colobomatous malformations. J Pediatr Ophthalmol Strabismus 1995; 32:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/70\">",
"      Drews RC. Heterochromia iridum with coloboma of the optic disc. Arch Ophthalmol 1973; 90:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/71\">",
"      Theodossiadis GP, Damanakis AG, Theodossiadis PG. Coloboma of the optic disk associated with retinal vascular abnormalities. Am J Ophthalmol 1995; 120:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/72\">",
"      Weaver RG, Cashwell LF, Lorentz W, et al. Optic nerve coloboma associated with renal disease. Am J Med Genet 1988; 29:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/73\">",
"      Sanyanusin P, McNoe LA, Sullivan MJ, et al. Mutation of PAX2 in two siblings with renal-coloboma syndrome. Hum Mol Genet 1995; 4:2183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/74\">",
"      Sanyanusin P, Schimmenti LA, McNoe LA, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995; 9:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/75\">",
"      Ford B, Rupps R, Lirenman D, et al. Renal-coloboma syndrome: prenatal detection and clinical spectrum in a large family. Am J Med Genet 2001; 99:137.",
"     </a>",
"    </li>",
"    <li>",
"     Mendelian Inheritance in Man. Papillorenal syndrome file://omim.org/entry/120330 (Accessed on August 16, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/77\">",
"      Russell-Eggitt IM, Blake KD, Taylor DS, Wyse RK. The eye in the CHARGE association. Br J Ophthalmol 1990; 74:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/78\">",
"      Pagon RA. Ocular coloboma. Surv Ophthalmol 1981; 25:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/79\">",
"      G&uuml;nd&uuml;z K, G&uuml;nalp I, Erden I. Focal dermal hypoplasia (Goltz's syndrome). Ophthalmic Genet 1997; 18:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/80\">",
"      Warburg M. Update of sporadic microphthalmos and coloboma. Non-inherited anomalies. Ophthalmic Paediatr Genet 1992; 13:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/81\">",
"      Diven DG, Solomon AR, McNeely MC, Font RL. Nevus sebaceus associated with major ophthalmologic abnormalities. Arch Dermatol 1987; 123:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/82\">",
"      Ascaso FJ, Del Buey MA, Huerva V, et al. Noonan's syndrome with keratoconus and optic disc coloboma. Eur J Ophthalmol 1993; 3:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/83\">",
"      Theodossiadis GP, Kollia AK, Theodossiadis PG. Cilioretinal arteries in conjunction with a pit of the optic disc. Ophthalmologica 1992; 204:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/84\">",
"      FERRY AP. MACULAR DETACHMENT ASSOCIATED WITH CONGENITAL PIT OF THE OPTIC NERVE HEAD. PATHOLOGIC FINDINGS IN TWO CASES SIMULATING MALIGNANT MELANOMA OF THE CHOROID. Arch Ophthalmol 1963; 70:346.",
"     </a>",
"    </li>",
"    <li>",
"     Brown GC, Tasman W. Congenital Anomalies of the Optic Disc, Grune &amp; Stratton, New York 1983. p.31.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/86\">",
"      Brown GC, Shields JA, Goldberg RE. Congenital pits of the optic nerve head. II. Clinical studies in humans. Ophthalmology 1980; 87:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/87\">",
"      Wise JB, MacLean AL, Gass JD. Contractile peripapillary staphyloma. Arch Ophthalmol 1966; 75:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/88\">",
"      Kiratli H, Bozkurt B, Mocan C. Peripapillary staphyloma associated with orofacial capillary hemangioma. Ophthalmic Genet 2001; 22:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/89\">",
"      Gottlieb JL, Prieto DM, Vander JF, et al. Peripapillary staphyloma. Am J Ophthalmol 1997; 124:249.",
"     </a>",
"    </li>",
"    <li>",
"     Duke-Elder S. Congenital deformities. In: System of Ophthalmology, Mosby, St. Louis 1963. Vol 3, p.661.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/91\">",
"      Kodama T, Hayasaka S, Setogawa T. Myelinated retinal nerve fibers: prevalence, location and effect on visual acuity. Ophthalmologica 1990; 200:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/92\">",
"      Straatsma BR, Foos RY, Heckenlively JR, Taylor GN. Myelinated retinal nerve fibers. Am J Ophthalmol 1981; 91:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/93\">",
"      Ellis GS Jr, Frey T, Gouterman RZ. Myelinated nerve fibers, axial myopia, and refractory amblyopia: an organic disease. J Pediatr Ophthalmol Strabismus 1987; 24:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/94\">",
"      Ali BH, Logani S, Kozlov KL, et al. Progression of retinal nerve fiber myelination in childhood. Am J Ophthalmol 1994; 118:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/95\">",
"      Kushner BJ. Functional amblyopia associated with abnormalities of the optic nerve. Arch Ophthalmol 1984; 102:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/96\">",
"      De Jong PT, Bistervels B, Cosgrove J, et al. Medullated nerve fibers. A sign of multiple basal cell nevi (Gorlin's) syndrome. Arch Ophthalmol 1985; 103:1833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/97\">",
"      Lorentzen SE. Drusen of the optic disc. Dan Med Bull 1967; 14:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/98\">",
"      Rosenberg MA, Savino PJ, Glaser JS. A clinical analysis of pseudopapilledema. I. Population, laterality, acuity, refractive error, ophthalmoscopic characteristics, and coincident disease. Arch Ophthalmol 1979; 97:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/99\">",
"      Puck A, Tso MO, Fishman GA. Drusen of the optic nerve associated with retinitis pigmentosa. Arch Ophthalmol 1985; 103:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/100\">",
"      Grover S, Fishman GA, Brown J Jr. Frequency of optic disc or parapapillary nerve fiber layer drusen in retinitis pigmentosa. Ophthalmology 1997; 104:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/101\">",
"      Edwards A, Grover S, Fishman GA. Frequency of photographically apparent optic disc and parapapillary nerve fiber layer drusen in Usher syndrome. Retina 1996; 16:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/102\">",
"      Nischal KK, Hingorani M, Bentley CR, et al. Ocular ultrasound in Alagille syndrome: a new sign. Ophthalmology 1997; 104:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/103\">",
"      Pierro L, Brancato R, Minicucci M, Pece A. Echographic diagnosis of Drusen of the optic nerve head in patients with angioid streaks. Ophthalmologica 1994; 208:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/104\">",
"      Beck RW, Corbett JJ, Thompson HS, Sergott RC. Decreased visual acuity from optic disc drusen. Arch Ophthalmol 1985; 103:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/105\">",
"      Kurz-Levin MM, Landau K. A comparison of imaging techniques for diagnosing drusen of the optic nerve head. Arch Ophthalmol 1999; 117:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/106\">",
"      Boldt HC, Byrne SF, DiBernardo C. Echographic evaluation of optic disc drusen. J Clin Neuroophthalmol 1991; 11:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/107\">",
"      Mustonen E, Nieminen H. Optic disc drusen--a photographic study. I. Autofluorescence pictures and fluorescein angiography. Acta Ophthalmol (Copenh) 1982; 60:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/108\">",
"      Bianchi-Marzoli S, Rizzo JF 3rd, Brancato R, Lessell S. Quantitative analysis of optic disc cupping in compressive optic neuropathy. Ophthalmology 1995; 102:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/109\">",
"      Kupersmith MJ, Krohn D. Cupping of the optic disc with compressive lesions of the anterior visual pathway. Ann Ophthalmol 1984; 16:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/110\">",
"      Hayreh SS, Jonas JB. Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology 2001; 108:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/111\">",
"      Brodsky MC. Periventricular leukomalacia: an intracranial cause of pseudoglaucomatous cupping. Arch Ophthalmol 2001; 119:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/112\">",
"      Jacobson L, Hellstr&ouml;m A, Flodmark O. Large cups in normal-sized optic discs: a variant of optic nerve hypoplasia in children with periventricular leukomalacia. Arch Ophthalmol 1997; 115:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/113\">",
"      Parmley VC, Schiffman JS, Maitland CG, et al. Does neuroretinitis rule out multiple sclerosis? Arch Neurol 1987; 44:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/114\">",
"      Liu GT, Galetta SL, Rorke LB, et al. Gangliogliomas involving the optic chiasm. Neurology 1996; 46:1669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/115\">",
"      Stark KL, Kaufman B, Lee BC, et al. Visual recovery after a year of craniopharyngioma-related amaurosis: report of a nine-year-old child and a review of pathophysiologic mechanisms. J AAPOS 1999; 3:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/116\">",
"      Wang YC, Huang JS, Wu CJ, et al. A huge osteoblastoma with aneurysmal bone cyst in skull base. Clin Imaging 2001; 25:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/117\">",
"      Yee RD, Cogan DG, Thorp TR, Schut L. Optic nerve compression due to aneurysmal bone cyst. Arch Ophthalmol 1977; 95:2176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/118\">",
"      Sullivan TJ, Wright JE. Non-traumatic orbital haemorrhage. Clin Experiment Ophthalmol 2000; 28:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/119\">",
"      Kaye LC, Kaye SB, Lagnado R, et al. Cerebral arteriovenous malformation presenting as visual deterioration in a child. Dev Med Child Neurol 2000; 42:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/120\">",
"      Ishikawa T, Ito T, Shoji E, Inukai K. Compressive optic nerve atrophy resulting from a distorted internal carotid artery. Pediatr Neurol 2000; 22:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/121\">",
"      Neumann D, Isenberg SJ, Rosenbaum AL, et al. Ultrasonographically guided injection of corticosteroids for the treatment of retroseptal capillary hemangiomas in infants. J AAPOS 1997; 1:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/122\">",
"      Curran EL, Fleming JC, Rice K, Wang WC. Orbital compression syndrome in sickle cell disease. Ophthalmology 1997; 104:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/123\">",
"      Castelnuovo P, Mauri S, Bignami M. Spontaneous compressive orbital emphysema of rhinogenic origin. Eur Arch Otorhinolaryngol 2000; 257:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/124\">",
"      Yavuzer R, Khilnani R, Jackson IT, Audet B. A case of atypical McCune-Albright syndrome requiring optic nerve decompression. Ann Plast Surg 1999; 43:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/125\">",
"      Birchall D, Goodall KL, Noble JL, Jackson A. Graves ophthalmopathy: intracranial fat prolapse on CT images as an indicator of optic nerve compression. Radiology 1996; 200:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/126\">",
"      Shapiro F. Osteopetrosis. Current clinical considerations. Clin Orthop Relat Res 1993; :34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/127\">",
"      Votruba M, Fitzke FW, Holder GE, et al. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol 1998; 116:351.",
"     </a>",
"    </li>",
"    <li>",
"     Online Mendelian Inheritance in Man. Optic atrophy 1. file://omim.org/entry/165500 (Accessed on August 16, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/47/6906/abstract/129\">",
"      Fein-Levy C, Gorlick R, Meyers PA, et al. Ewing's sarcoma in a patient with congenital optic atrophy. J Pediatr Hematol Oncol 1998; 20:577.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6267 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-782CD78CC9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6906=[""].join("\n");
var outline_f6_47_6906=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H721520758\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CONGENITAL ANOMALIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Disc size",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Aplasia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Hypoplasia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Megalopapilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Disc conformation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Tilted discs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Morning glory disc",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Optic disc coloboma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Optic pit",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Peripapillary staphyloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pseudoswelling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Hyperopia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Myelinated fibers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Optic disc drusen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Bergmeister papilla",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ACQUIRED ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Cupping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Swelling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Papilledema",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Ischemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Compression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Infiltration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Atrophy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Diffuse atrophy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Segmental atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H721520758\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6267\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6267|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/1/4112\" title=\"picture 1\">",
"      Normal optic disc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/27/4528\" title=\"picture 2\">",
"      Optic nerve hypoplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/34/11823\" title=\"picture 3\">",
"      Tilted disc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/31/40433\" title=\"picture 4\">",
"      Morning glory disc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/27/1457\" title=\"picture 5\">",
"      Optic nerve coloboma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/29/37343\" title=\"picture 6\">",
"      Optic pit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/0/15360\" title=\"picture 7\">",
"      Peripapillary staphyloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/54/23392\" title=\"picture 8\">",
"      Pseudopapilledema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/55/10096\" title=\"picture 9\">",
"      Myelinated nerve fibers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/1/43039\" title=\"picture 10\">",
"      Optic disc drusen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/61/35807\" title=\"picture 11\">",
"      Bergmeister papilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/28/7616\" title=\"picture 12\">",
"      Normal physiologic cupping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/19/20799\" title=\"picture 13\">",
"      Glaucomatous optic disc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/6/3169\" title=\"picture 14\">",
"      Optic disc swelling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/59/5040\" title=\"picture 15\">",
"      Neuroretinitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/34/7712\" title=\"picture 16\">",
"      Sectoral disc swelling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/1/8210\" title=\"picture 17\">",
"      Optic disc infiltration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/62/26592\" title=\"picture 18\">",
"      Diffuse optic atrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/20/320\" title=\"picture 19\">",
"      Inferior segmental atrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/13/14544\" title=\"picture 20\">",
"      Temporal segmental atrophy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18506?source=related_link\">",
"      Bone and joint complications in sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22761?source=related_link\">",
"      Cataract in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35575?source=related_link\">",
"      Congenital anomalies of the nose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/54/5994?source=related_link\">",
"      Hydrocephalus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17417?source=related_link\">",
"      Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/5/44121?source=related_link\">",
"      Nevoid basal cell carcinoma syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9464?source=related_link\">",
"      Optic neuritis: Pathophysiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29944?source=related_link\">",
"      Optic neuritis: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30552?source=related_link\">",
"      Overview and differential diagnosis of papilledema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3432?source=related_link\">",
"      Pathogenesis and clinical features of Graves' ophthalmopathy (orbitopathy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/57/5016?source=related_link\">",
"      Primary infantile glaucoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10935?source=related_link\">",
"      Renal hypoplasia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_47_6907="Pain synd cancer";
var content_f6_47_6907=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F71104&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F71104&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Acute pain syndromes directly related to cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Acute pain syndromes directly related to cancer:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rupture of hepatocellular carcinoma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pathologic fractures from bone metastases (vertebral or long bones)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Acute intestinal/biliary/ureteric obstruction or perforation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Acute pain syndromes associated with infections:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Herpes zoster and postherpetic neuralgia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Acute pain syndromes associated with thrombotic events:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Deep vein thrombosis (upper and lower extremities)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Superior vena cava obstruction",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6907=[""].join("\n");
var outline_f6_47_6907=null;
var title_f6_47_6908="Intel disabil terms";
var content_f6_47_6908=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57206&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57206&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Terminology used to describe intellectual disability in different countries",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Country and/or language",
"       </td>",
"       <td class=\"subtitle1\">",
"        Term",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        United States",
"       </td>",
"       <td>",
"        Intellectual disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Australia",
"       </td>",
"       <td>",
"        Intellectual disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Canada (English, French)",
"       </td>",
"       <td>",
"        Mental deficiency, intellectual handicap",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        England",
"       </td>",
"       <td>",
"        Learning disability*, intellectual disability, developmental disability",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        France",
"       </td>",
"       <td>",
"        Mental deficiency, mental apraxia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Germany",
"       </td>",
"       <td>",
"        Mental handicap, mental retardation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Italy",
"       </td>",
"       <td>",
"        Mental delay, mentally deficient",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Estonia",
"       </td>",
"       <td>",
"        Mental retardation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Puerto Rico",
"       </td>",
"       <td>",
"        Mentally slowed down",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spain",
"       </td>",
"       <td>",
"        Mental delay",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * In the United States, the term \"learning disability\" usually denotes a specific learning disability (eg, dyslexia) rather than intellectual disability.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      In the United States, the term \"developmental disability\" does not necessarily involve intellectual disability. For example, a developmental disability could be limited to motor dysfunction or developmental-behavioral dysfunction, in the absence of intellectual disability.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Schroeder SR, Gerry M, Gertz G, Velazquez F. Usage of the Term \"Mental Retardation:\" Language, Image and Public Education. Kansas University Center on Developmental Disabilities; Center for the Study of Family, Neighborhood and Community Policy, The University of Kansas. 2002. p.86.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6908=[""].join("\n");
var outline_f6_47_6908=null;
var title_f6_47_6909="Canada Guide timing age kid tx";
var content_f6_47_6909=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F54575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F54575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        General considerations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Recommendations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. All patients with end-stage renal disease should be considered for kidney transplantation provided no absolute contraindications exist (Grade A).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Eligibility for kidney transplantation should be determined on medical and surgical grounds. Criteria for eligibility should be transparent and made available to patients and the public. Eligibility should not be based on social status, gender, race or personal or public appeal (Grade C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. A patient declined for transplantation should routinely be offered a second opinion from an alternative physician or surgeon or a committee able to assess the relative risks and benefits of kidney transplantation (Grade C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Timing of referral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Recommendations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Potential transplant recipients should be referred for evaluation by a transplant program once renal replacement therapy is expected to be required within the next 12 months (Grade C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Patients already requiring dialysis support should be referred for transplant evaluation as soon as their medical condition stabilizes (Grade C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Renal function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Recommendations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Preemptive kidney transplantation is the preferred form of renal replacement therapy and should be encouraged where feasible (Grade A).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Preemptive kidney transplantation should not proceed unless the measured or calculated glomerular filtration rate is &lt;20 mL/minute and there is evidence of progressive and irreversible deterioration in renal function over the previous 6-12 months. Exceptions may be made for patients receiving combined organ transplants where a kidney transplant is combined with a non-renal organ. However, the appropriate policy on this issue is not clear at this time (Grade C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Age and functional capacity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Recommendations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Advanced age per se is not a contraindication to kidney transplantation (Grade B).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Transplant candidates should have a reasonable probability of surviving beyond current waiting times for transplantation, given the resources required to assess and maintain patients on the renal transplant waiting list (Grade C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Very young age and small size should not prevent early referral for transplant evaluation (Grade B).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Cognitive or neurodevelopmental delay is not an absolute contraindication to renal transplantation in children (Grade B).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The strength of evidence supporting each recommendation was graded using the system developed by the Canadian Task Force on Preventive Health Care as follows:",
"     <br>",
"      Grade A - There is good evidence to support",
"      <br>",
"       Grade B - There is fair evidence to support",
"       <br>",
"        Grade C - The existing evidence is conflicting, but other factors may influence decision-making",
"        <br>",
"         Grade D - There is fair evidence to recommend against",
"         <br>",
"          Grade E - There is good evidence to recommend against",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Knoll, G, Cockfield, S, Blydt-Hansen, T, et al. Canadian Society of Transplantation: Consensus guidelines on eligibility for kidney transplantation. CMAJ 2005; 173:S1. Copyright &copy; 2005 CMA Media Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6909=[""].join("\n");
var outline_f6_47_6909=null;
var title_f6_47_6910="TIA symptoms and vascular territories";
var content_f6_47_6910=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F71676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F71676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Symptoms of transient ischemic attacks and the vascular territories involved",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        ICA/MCA",
"       </td>",
"       <td class=\"subtitle1\">",
"        VA/BA",
"       </td>",
"       <td class=\"subtitle1\">",
"        PCA",
"       </td>",
"       <td class=\"subtitle1\">",
"        Lacunes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Visual abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Transient monocular blindness",
"       </td>",
"       <td>",
"        ++++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hemianopia",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Blindness",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Motor abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hemiparesis",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Quadraparesis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"5\">",
"        Single part weakness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Face",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        ++",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Arm/hand",
"       </td>",
"       <td class=\"sublist_other\">",
"        +++",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Thigh/leg/foot",
"       </td>",
"       <td class=\"sublist_other\">",
"        ++",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Crossed weakness*",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Limb ataxia/weakness",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gait ataxia",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Sensory abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hemisensory",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"5\">",
"        Single part sensory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Face",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        ++",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Arm/hand",
"       </td>",
"       <td class=\"sublist_other\">",
"        ++",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        ++",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Thigh/leg/foot",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Crossed sensory*",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Cognitive abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aphasia",
"       </td>",
"       <td>",
"        ++++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Amnesia",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alexia",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Abulia",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Cranial nerve symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vertigo",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diplopia",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dysarthria",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dysphagia",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tinnitus/hearing loss",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ++++",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ICA: internal carotid arteries; MCA: middle cerebral arteries; VA: vertebral arteries; BA: basilar artery; PCA: posterior cerbral arteries.",
"     <br/>",
"     * Crossed weakness or crossed sensory refers to one side of the cranial structures and the opposite side limbs and trunk.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6910=[""].join("\n");
var outline_f6_47_6910=null;
var title_f6_47_6911="Reimplantation avulsed teeth";
var content_f6_47_6911=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81527&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81527&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 513px\">",
"   <div class=\"ttl\">",
"    Reimplantation of avulsed teeth",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 493px; height: 108px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The tooth should be handled carefully by the crown to prevent damage to the periodontal ligament. Debris should be removed by gentle rinsing with saline or tap water; attempts should not be made to sterilize or scrub the tooth. The tooth should be manually reimplanted in the socket (C). The tooth is kept in place by the child through finger pressure or by biting on a gauze pad.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from McTigue DJ. Managing traumatic injuries in the young permanent dentition. In: Pediatric Dentistry: Infancy through adolescence, 4th ed, WB Saunders, Philadelphia 2005. Copyright &copy; 2005 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_47_6911=[""].join("\n");
var outline_f6_47_6911=null;
